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Microneedle (MN) based electrochemical (bio)sensing has become a growing field within the discipline
of analytical chemistry as a result of its unique capacity for continuous, decentralized health status
monitoring. There are two significant advantages to this exclusive feature: i) the ability to directly
analyze interstitial fluid (ISF), a body fluid with a similar enough composition to plasma (and blood) to be
considered a plentiful source of information related to biologically relevant molecules and biomarkers;
and ii) the capacity to overcome some of the major limitations of blood analysis including painful
extraction, high interferant concentrations, and incompatibility with diagnosis of infants (and especially
newborns). Recent publications have demonstrated important advancements in electrochemical MN
sensor technology, among which are included new MN fabrication methods and various modification
strategies, providing different architectures and allowing for the integration of electronics. This versa-
tility highlights the undeniable need for interdisciplinary efforts towards tangible progress in the field. In
a context evidently dominated by glucose sensing, which is slowly being expanded towards other
analytes, the following crucial questions arise: to what extent are electrochemical MN (bio)sensors a
reliable analytical tool for continuous ISF monitoring? Which is the best calibration protocol to be fol-
lowed for in vivo assays? Which strategies can be employed to protect the sensing element during skin
penetration? Is there an appropriate validation methodology to assess the accuracy of electrochemical
MN (bio)sensors? How significant is the distinction between successful achievements in the laboratory
and the real commercial feasibility of products? This paper aims to reflect on those previous questions
while reviewing the progress of electrochemical MN (bio)sensors in the last decade with a focus on the
analytical aspects. Overall, we describe the current state of electrochemical MN (bio)sensors, the benefits
and challenges associated to ISF monitoring, as well as key features (and bottlenecks) regarding its
implementation for in vivo assays.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Two principal driving forces have, over the past few years, given
rise to a new analytical philosophy of decentralized clinical diag-
nosis. These are, more specifically, shortcomings which have been
identified in the healthcare system and an ever-growing popula-
tion, resulting in saturation of services as well as increasing costs. In
this context, a multitude of research papers have been recently
published on new paths for point-of-care (POC) diagnostic devicesacp@kth.se (G.A. Crespo).
hare the first author.
r B.V. This is an open access articlewith the promise to gather valuable patient health information,
from within their own homes [1e5]. Common among all these
devices, is the objective of developing robust and reliable tools to
detect biomarkers in assessing human health at any time and place.
For this purpose, wearable sensor technology is the approach that
seems to best fulfil all the requirements for implementation in POC
protocols; the minimally invasive nature of this technology coupled
with the possibility to perform the analysis without need of a
medical expert are highly appealing features [6,7]. In particular,
electrochemical (bio)sensors stand out among readout options
because of their excellent analytical features (i.e., high sensitivity,
fast response time, and versatility) and inherent characteristics (i.e.,
ease of miniaturization, simplicity, low cost) [8]. Furthermore, the
implementation of different electroanalytical techniques (e.g.under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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spectroscopy) and sensor development principles (e.g. ion-
selective membranes, biofunctionalization) allow for the determi-
nation of a wide range of clinically relevant analytes, of both inor-
ganic and organic nature [9,10].
The determination of health-related targets can be performed in
different body fluids; at the time of writing blood and urine are the
most heavily analyzed samples. However the spread of wearable
sensors highlights the importance of analyzing easily body fluids
beyond blood and urine, for instance sweat [11,12], tears [13] and
saliva [14]. Note that the composition of these matrices is quite
different from blood [15], and therefore, it not always the same kind
of information which is obtained. Thus, correlation studies are of a
paramount importance (despite being almost absent in the litera-
ture) to shed light on the utility of these sorts of analyses. In
contrast, the interstitial fluid (ISF) seems to more precisely mirror
the composition of blood serum [10]. Indeed, ISF is the fluid where
body cells are embedded and has proven to be a rich source of
biochemical information [6]. For example, Samavat et al. monitored
glucose in ISF for 3 h and found acceptable correlation to concen-
tration values observed through blood obtained by a finger-prick
method [16]. Although ISF offers such advantageous opportu-
nities, access to this fluid is limited by the physical barrier of the
skin. Fortunately, microneedles (MNs) can overcome this barrier in
order to reach ISF in a painless and effective manner. MNs are
similar to intradermal needles but with microscale dimensions
(typical length of 1000 mm) and have been widely investigated as a2
drug delivery platform, which currently represents a strong
research field [17e21]. By contrast, employment of MNs in wear-
able electrochemical sensors is relatively recent. Results thus
indicate a minimally invasive method involving painless skin
insertion, which provides easy on-body portability and the possi-
bility of implementation for the continuous biomarker monitoring.
The application of MN sensors would therefore be of primary
benefit to the field of healthcare, as illustrated in Fig. 1. Facile and
continuous monitoring of biomarkers is crucial in hospital facilities
- in particular, Intensive Care Units (ICUs) e for patients ranging
from adults to newborns; MN-based platforms could provide un-
precedented real-time information about the patient's status and
enable early medical actions, which would undoubtedly help to
improve patient survival rates [22]. To demonstrate this signifi-
cance, we have collected in Table 1 key analytes traditionally
evaluated in ICUs, alongside their detection relevance and main
diseases with which they are associated. It is not overly ambitious
to believe that the great majority of these targets could be moni-
tored in the future byMN sensors to assess a complete evaluation of
patients' evolution, even as they experience a life-threatening
condition such as sepsis. Besides ICU application, the use of MN
sensors in emergency rooms, and for the daily monitoring of
chronic patient status (in the clinic or even from their own home)
would grant a measure of independence to end users. This would
hence improve the life quality of lay citizens while decreasing the
pressure on the health care system in terms of personnel, space and
resources (economic gains). Another field inwhichMN sensorsmay
Fig. 1. Graphical concept. Application of microneedle-based sensors in the healthcare sector.
Table 1
Clinical relevance claimed for several analytes mainly considering reports on ICU environments.
Analyte Priority Related diseases Ref
Sodium Medium-High Fluid loss, cystic fibrosis [46e49]
Potassium Medium Arrhythmia, renal failure, sepsis, reduced gut motility, cystic fibrosis, spreading
depression
[46e48,50]
Chloride High Sodium and acid-base disturbances, cystic fibrosis, spreading depression [46e50]
pH High Metabolic and respiratory acidosis, sepsis, spreading depression [50,51]
Calcium High Coagulopathy, osteopenia, neuromuscular excitability, cardiovascular
complications, secondary hyperparathyroidism, myeloma
[52e54]
Phosphate Medium Osteopenia, arrhythmias, ventilatory insufficiency [47]
Bicarbonate Medium Metabolic acidosis, renal-tubular dysfunction, sepsis [51,55]
O2 (PaO2) High Lung failure, hypoxia [56]
CO2 (PaCO2) High Lung failure, hypoxia [56]
Glucose High Diabetes, occasions for hyper/hypoglucemia [57]
Lactate High Sepsis, tissue hypoxia, arthritis, renal and hepatic diseases [58,59]
Pyruvate Medium Renal and hepatic diseases, lactic acidosis [58]
Uric acid Medium Gout, sepsis, kidney diseases [60,61]
Creatinine High Sepsis, asphyxia, renal diseases (especially after renal replacement therapy) [62]
Cortisol High Sepsis, stress [63]
Adrenaline High Cardiac arrest, resuscitation [64]
Bilirubin High Sepsis, acute respiratory distress syndrome [65,66]
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sport. Continuous monitoring of several speciese such as lactate or
common ions (electrolytes) e while practicing physical activity
would provide useful datasets that coaches and athlete support
teams may use to optimize effort invested towards maximum
reward at minimum health risk.
Despite this huge potential, efforts in the field thus far have been
quite timid when compared with the forecasted capabilities of MN
(bio)sensors. For example, recent efforts have been primarily
devoted to glucose monitoring for diabetes control, with a great
variety of research papers applying different methodologies
[23e32]. Other metabolites such as lactate [33], alcohol [34], pH
[35], cholesterol [36] or benzoquinone [37] have recently begun to
attract more attention. Beyond reporting fabrication approaches
and the required protocol for the analytical readout, only a small
percentage of these papers has shown successful in vivo applica-
tions. In our opinion, one of the reasons for this lack of applications3
in real contexts is the necessity for non-toxic, biocompatible ma-
terials, and the need to assure that no substance can leak from the
MN sensor into the body in question. Moreover, both the proper
calibration and validation of MN (bio)sensors are still challenges
that must be tackled in ISF transdermal analysis. One major
obstacle to this process is the lack of suitable methods for extrac-
tion of ISF for validation purposes. Some approaches have been put
forward [38], but as yet no clear methodology is available in the
literature. Finally, both robustness and flexibility are mandatory
properties for wearable sensors, even more strictly so in the case of
sporting health applications due to the extrememovement range of
the subjects. Taken altogether, this results in a disproportionately
small market for commercial MN sensors which is dominated by a
few examples of glucose monitoring devices [39,40].
Hence, the present review focuses on the main advances ach-
ieved in the electrochemical MN (bio)sensors field in the last
decade. Other works have already thoroughly reviewedMN sensors
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the analytical viewpoint of electrochemical MN (bio)sensors. It
should be stressed that our primary aim is to provide an accurate
overview of this field, and that it is not our intention to disregard
every work reporting on the electrochemical MN field during the
selected period. All the data hereby presented were collected from
the original research papers with the unique purpose to offer an
exhaustive insight into the topic and analyze its current state. The
first part of this review is dedicated to understanding the skin
composition and the physical characteristics required for MNs to be
able to painlessly reach ISF. Next, the in vitro analytical performance
of the reported sensors is critically reviewed, highlighting the most
successful approaches and deriving therefrom the most crucial
parameters for success. Finally, a discussion regarding the main
advances and difficulties encountered in the implementation of
electrochemical MN sensors for in vivo analysis is provided, thereby
envisioning the real market demands. Overall, this review seeks to
provide a realistic insight on the most urgent aspects of the field,
and the direction in which should future studies be focused.
2. Understanding the biology behind MN sensors
2.1. The skin: a complex organ in the human body
The MN has a double purpose in the wearable settings: (i) to
disrupt the skin barrier to gain access to the ISF and/or blood, and
(ii) to act as the platform for the sensing element. Evidently, to
develop reliable and suitable MN sensors, it is crucial to first un-
derstand the skin structure. When measured by surface area, the
skin is one of the largest organs in the human body (second only to
the small intestine) with an average surface area in adults of
around two square meters. Skin thickness presents a wide vari-
ability depending on the part of the body that is examined. For
example, the thickest skin is to be found in the palms of the hand
and the soles of the feet, while the thinnest skin is located around
the eyelids [67]. The functions of this organ include protection
against chemical, radiation and biological threats (bacteria, al-
lergens and fungus), retainment of water and nutrients, heat
regulation, water resistance, and adsorption/excretion processes.
This versatile functionality of skin is related to its complex
structure [68]. Due to this complexity, this review analyzes basic
aspects on the structure, exclusively dealing with the aspects
which have a direct guiding hand in the mechanical design of MN
(bio)sensors for successful penetration. Briefly, the structure of
skin can be understood as being composed of three layers:
epidermis (outer layer), dermis (middle layer), and hypodermis
(inner layer), as illustrated in Fig. 2 [69].
The epidermis thickness generally varies between 50 and
150 mm (thicker skin is found in palms and soles), and its cell
composition ranges from anuclear cells in the outermost parts to
hexagonal-shaped cells in the innermost. Epidermis is principally
divided in two sublayers, stratum corneum (SC) and viable
epidermis, with the first layer being lipophilic and the second
hydrophilic. The SC is the external layer of epidermis, and it has
been demonstrated that this layer constitutes the principal barrier
towards drug penetration. SC thickness is about 10 mm but can
reach 400 and 600 mm in the palms and soles. The viable dermis
then, also known as the stratum basale, contains a higher water
content than the SC [70], and demarcates the boundary line be-
tween the end of the epidermis and the beginning of the dermis.
The thickness of the dermis varies between approximately 500
and 2000 mm and is composed primarily of fibroblasts, collagens
and elastic fibers. Dermis is the skin layer where nerves, blood
vessels, sweat glands and derma lymph nodes start to appear [41].
The pressure needed to penetrate this layer is about 1e5 MPa [71].4
Finally, the innermost layer (hypodermis) is the thickest of all the
three. Constructed out of connective tissues and fibrous collagen,
in some regions of the body this wall can be several millimetres
thick. Adipocytes, fibroblasts and macrophages occur in this area.
In addition, nerves, arteries, veins and lymphatic glands are much
more densely congregated in this zone. The hypodermis is rele-
vant in several physiological pathways such as homeostasis, lipid
regulation/fluid distribution, thermal equilibrium; moreover it
acts as energy reservoir as well as providing bonding tissues to
muscles and bones [70].
2.2. Interstitial fluid as an alternative source for obtaining chemical
information
In the pipeline design of MN (bio)sensors, the very first thing to
be selected is the biological fluid under study, this will define most
of the mechanical properties required for the MN substrate (length,
shape, rigidness, and thickness among others). In principal, as
blood is considered the primary biological fluid source of
biochemical information it is generally the first choice among such
fluids for analysis. In addition, the composition of blood updates
itself continuously as the health status of the patient changes. Blood
vessels can be found in the dermis layer, to a depth ranging from
500 to 2000 mmdepending on the body zone. According to the final
dimensions needed for skin penetration, both macroscale needle
and microneedle (MN) based sensors can be appropriate. However,
we have found that all blood sensors in the literature tend to be
referred to as MN blood sensors regardless of the actual di-
mensions, especially in terms of length [16,72]. The same applies to
some cases involving MN sensors for cerebrospinal fluid (CSF) and
organ tissue penetration during surgeries [73]. This is the result of
unclear consensus in the general definition of a MN: in terms of
length, the upper limit varies from 1000 to 2500 mm, while ranges
of 50e250 mm and 1e25 mm appear to have been established for
the base and tip diameter respectively [74e78]. In addition to this,
blood analysis bymeans of MN sensors (in themost general context
of dimensions) presents some drawbacks that should be stressed at
this point: i) the large amount of interfering species present in
blood can lead to severe fouling problems for sensors; and ii) an
ideal continuous monitoring scenario with MNs should involve the
least disruption possible for the patient, avoiding any interferences
with normal activities and daily routines. Regarding this latter
point, it is evident that the place for implanting the MN (bio)sensor
should exceed traditional finger pricks measurements.
The use of ISF as an analytical fluid sample has the potential to
overcome these limitations: ISF is found in the subcutaneous tissue
and therefore can be accessed by MNs with reduced length and
more painless insertion. This would in principal allow for a more
accessible continuous monitoring over a period of hours to days, or
even longer in an ideal case. Furthermore, MNs may provide a
method of ISF collection for the purposes of validation [79]. Reverse
iontophoresis is a further method that could potentially be put to
this use [6]. For example, reverse iontophoresis was successfully
applied for glucose detection using biosensors embedded into
epidermal patches or devices (such as the GlucoWatch) with
promising results [10,11]. However, special attention should be paid
to the applied electrical pulses to avoid additional disturbance in
the form of pain or even side effects to the patient. Indeed, this
eventually proved a reason for the withdrawal of the GlucoWatch
from the market [6].
In terms of composition, ISF is furnished with nutrients and
oxygen by diffusion processes from the dermis, which is in turn
refreshed by blood capillaries. This diffusion process is quite com-
plex due to the involvement of both superficial plexus
(300e600 mm in depth, contains small blood vessels) and lower
Fig. 2. Scheme of skin layers structure.
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veins derived from muscles, lipids and subcutaneous tissues). As a
result, there is a noticeable nutrient gradient along the skin, with a
higher ratio of replenishment in the deeper zones [41]. Neverthe-
less, there is an equilibrium between ISF and plasma maintained by
several small molecules (e.g. albumin, CO2, phosphates) [80]. Thus,
the composition of ISF is to some extent similar to blood with the
exception of the absence of blood cells. Note that remarkable
similarities in the protein (93.3%) [81], metabolites (79.3%) [82] and
RNA (92.5%) [79] composition have been widely demonstrated.
Slight differences include both a lower protein concentration and
lower levels of some ions such as calcium, magnesium, sodium and
potassium. Table 2 depicts normal values of the major metabolites
and ions found in ISF and in blood for comparison. In the case of
larger molecules such as glucose, a correspondence between both
fluids can be observed. Nonetheless, fast changes in blood glucose
are slowly encompassed (and therefore manifested) in ISF, with the
rate being principally limited by the diffusion of these molecules
through the endothelium [41]. Regarding this lag time, it has been
demonstrated that there is an average time requirement of be-
tween 8 and 10 min to equilibrate concentrations in the two fluids,
but even higher values (even 45 min) have been reported in some
cases [69,83,84].
Overall, ISF shares enough composition with plasma (or blood)
to be a valuable source of information regarding many biologically
relevant molecules and biomarkers while avoiding the need for
direct blood analysis. As an additional benefit, the issues of surface
fouling are significantly decreased for ISF in comparisonwith blood
as a result of the lower concentrations of proteins and other large
molecules in this former [6], hence facilitating a long-term elec-
trochemical readout. Thus, ISF analysis by means of MN (bio)sen-
sors clearly represents a great potential towards the achievement of
continuous monitoring in a minimally invasive assembly.
2.3. Requirements in MN geometrical and mechanical properties
Fig. 3 illustrates the main parameters to be considered in the
development of MN sensors considering three key aspects: resis-
tance to skin penetration, pain inflicted to the end-user, and target
body fluid. In terms of resistance to skin penetration, parameters
such as length, material type, shape, tip angle, and insertion force5
are important for the development of a robust device able to reach
the SC (or even deeper) with minimal penetration effort and, as a
result, minimal discomfort for the individual. To establish a suitable
design, it is necessary to assess separately the distinct layers of SC,
viable epidermis, and dermis. Each one displays different me-
chanical properties and depths, which can be affected by various
factors such as body region, hydration level and even alimentary
diet. Furthermore, skin viscoelasticity is another factor to deal with
during penetration in in vivo assays [41].
Several studies have determined Young's Modulus for SC, viable
epidermis and dermis, with the derived results being 1e1000 Mpa
[92], 2e20MPa [93] and 10 kPa [94], respectively. In addition, it has
also been proved that the nonlinear viscoelasticity of skin is better
addressed by high velocity procedures (1e10 m s1) [95] which
allow a more reliable insertion. Regarding the required force, Davis
et al. were pioneers in establishing a safety margin for several MN
geometries based on the ratio between the insertion and the force
required to collapse a MN [96]. Likewise, other authors have
focused their research towards a better understanding of the
insertion step and the influence of different mechanical properties
of the needles, such as relationship between the axial and trans-
versal fractures and the Young's Modulus of the material used [97],
suitability of the base diameter for the insertion [98] and shape of
the MN [99], among others.
Regarding the length of the MN, a compromise is needed be-
tween a few parameters: it must be long enough to penetrate the
desired skin layer but not so long as to foment axial fracture.
Overall, the ideal MN should have minimised tip radius (5e80 mm)
to favor the insertion; sufficient base diameter (100e200 mm), wall
thickness (5e60 mm) and Young's Modulus to avoid fractures; a
well-designed tip geometry (i.e. conical, cylindrical, pyramidal)
[99] to minimize the force required for the insertion; and appro-
priate length to reach the target body fluid (below 600 mm for ISF
and ca. 1000e2000 mm for blood). Some viable dimensions and
geometries that have been reported for MN electrochemical sen-
sors targeting different biological fluids are summarized in Table 3,
as possible reference for success. Nevertheless, the reader must
notice that the majority of these papers are not demonstrated for
in vivo applications despite claiming that the MN (bio)sensors have
been designed for such purpose. On the other hand, while it seems
indubitable that ISF can be reached by MN devices for sensing
Table 2
Normal values of the main metabolites and ions in blood and ISF.
Analyte ISF concentration (mM) Blood concentration (mM) Ref
Total protein content 20.6 (g L1) 73.7 (g L1) [85]
Albumin 0.188 0.676 [85]
Ca2þ 1.183 1.257 [85]
Mg2þ 0.506 0.532 [85]
Naþ 135.7 141.8 [85]
Kþ 3.17 4.28 [85]
CO2 23.9 29.7 [85]
Phosphate 0.610 1.117 [85]
pH <7.35 7.35e7.45 [86]
Glucose 5.2 ± 0.8 4.9 ± 0.4 [87]
Lactate 1.12 ± 0.23 0.78 ± 0.18 [88]
Pyruvate 0.10 ± 0.01 0.12 ± 0.01 [88]
Glycerol 0.22 ± 0.03 0.038 ± 0.003 [88]
Urea 5.8 ± 0.4 4.8 ± 0.3 [88]
Total cholesterol 0.9 ± 0.2 4.4 ± 0.8 [89,90]
Glutamate 0.043 ± 0.008 0.042 ± 0.004 [91]
Alanine 0.25 ± 0.02 0.24 ± 0.03 [91]
Cysteine 0.034 ± 0.004 0.049 ± 0.002 [91]
Glycine 0.57 ± 0.09 0.194 ± 0.015 [91]
Serine 0.19 ± 0.02 0.10 ± 0.01 [91]
Total amino acids 2.61 ± 0.15 1.91 ± 0.08 [91]
Fig. 3. Main features (target, pain and resistance) and their relationship with mechanical and geometrical parameters of the MNs.
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tissues could be questionable in terms of pain and invasiveness.
Discomfort or pain caused to the patient by insertion of the
needles is an important aspect that must be considered. Accord-
ingly, several studies have sought to quantify the pain caused by
MNs and MN arrays to volunteers. Authors have evaluated the in-
fluence of several mechanical properties such as length, base6
diameter, thickness, number of MNs per array and tip angle
[72,100,101]. Direct correlation between the pain caused to the
patient and the length (up to 1450 mm) and number ofMNs inserted
(up to 50) was observed. Contrarily, no pain influence was noted in
the assays with different thickness or tip angle, up to values of
100 mm and 90, respectively. Finally, all patients stated that the
pain imposed by MNs was always lower than that caused by the
Table 3
Physical characteristics and fabrication methods of MN sensors.
Type of MN Substrate Material Fabrication Method Length
(mm)
Base
diameter
(mm)
Tip
diameter
(mm)
Hole
diameter
(mm)
Biological
fluid
Ref
Hollow Polymer (Eshell 200) filled with
carbon paste
Micromachining 700 800a <10 e ISF [105]
Solid Polymer (E-shell 200) Computer assisted UV
polymerization
818 390 NS e Serumc [114]
Hollow Polymer (E-shell 200) Computer assisted UV
polymerization
1366 1174a NS 342 Serumc [114]
Hollow Proline/Silk/D-Sorbitol Mold-filling followed by
thermal curing
800 400 NS NS ISF [23]
Solid Polymer (PET) Laser cutting 1500 700 NS e ISF [134]
Solid Poly(lactic acid)/f-MWCNT Mold-filling followed by
thermal curing
870 250 40 e ISF [122]
Hollow Polymer (Eshell 200) filled with
carbon paste
Computer assisted UV curing 1500 1250a NS 425 ISF [106e109]
Solid Resin (TMPTA) Mold-filling followed by UV
curing
600 NS 200 e ISF [129]
Porous Poly lactic-co-glycolic acid Thermal drawing lithography
followed by salt leaching
300 300 30 e ISF [27]
Hollow Polymer (Eshell 200) filled with
carbon paste
Computer assisted UV curing 800 NS NS 425 ISF [37]
Solid Polycarbonate coated with Cr/Pt Injection mold-filling 1000 600 40 e ISF [117]
Solid Polycarbonate coated with Pt/IrOx Injection mold-filling 1000 600 40 e ISF [118]
Hollow Polymer (USP4) Injection mold-filling 800 320e460 NS 100 ISF [34]
Solidf Polymer (PEG) Mold-filling followed by UV
curing
1000 300 NS e ISF [135]
Solid Polymer (PEGDA) Photolithography 500 NS NS e ISF [131]
Hollow Polymer (Eshell 300) filled with Au Two-photon polymerization 1000 500 NS NS ISF [110]
Solid Polymer (SU8) coated with Ti/Pt Mold-filling followed by UV
curing
1000 600 35 e ISF [102]
Solid Polymer (NOA68) coated with Au Mold-filling followed by UV
curing
280 190 <0.1 e ISF [31]
Solid Polymer (SU8) coated with Au Photolithography 200e400 73e136 38e101 e ISF [103]
Hollow Polymer (E-shell 200) filled with
carbon fibers
Computer assisted UV
polymerization
1500 1200a NS 400 ISF [113]
Solid- Polycarbonate coated with Au Injection mold-filling 1000 600 20 e ISF [33,115,116]
Hollow Polymer (Eshell 200) filled with
carbon paste
Computer assisted UV
polymerization
1500 1200a NS 400 ISF [112]
Solid Polymer (COC) coated with Au Mold-filling followed by
thermal curing
700 100 NS e Blood [24]
Solid Polymer (SU8) coated with C Mold-filling 1500 NS NS e Blood [16]
Solid Polymer (SU8) Photolithography followed by
wet etching
3000 100  50b NS e BISF [104]
Solid Polymer (PET) coated with Au/IrOx Injection mold-filling 1600 800 50e80 e Heart fluid [136,137]
Solid Carbon loaded polystyrene Mold-filling followed by
solvent evaporation
700 200 NS e Bloodd [130]
Solid CMRF coated with Ti/Au Magnetorheological drawing
lithography
600 365 12 e ISF [120]
Solid CMRF coated with Ti/Au Magnetorheological drawing
lithography
600 650 10 e Serumc,e [36]
Solid CMRF coated with Ti/Au Magnetorheological drawing
lithography
700 185 5 e NS [121]
Solid Stainless steel coated with Pt/rGO Laser micromachining 800 225 NS e ISF [124]
Solid Stainless steel coated with carbon Commercial 1000 450 15 e ISF [138]
Solid Stainless steel Laser microetching 680 250 200 e ISF [129]
Solid Stainless steel coated with Pt Commercial 680 250 NS e ISF [139]
Solid Stainless steel coated with AuNP/
PtNP
Commercial NS 180 NS e Blood [140]
Solid Stainless steel coated with Au and
Pt black
Micromachining with a jet of
ferric chloride
600 100 NS e Serumc [26]
Solid Stainless steel coated with C film/
Ni6MnO8
Hydrothermal reaction
calcination
1300 250 NS e NS [125]
Solid Tungsten coated with ZnO Commercial 30,000 300 NS e CSF and bladder [73]
Solid Titanium coated with N-UNCD Laser micromachining 340 230 10e20 e ISF [141]
Solid Gold Mold-filling followed by
thermal curing
290 190 10 e ISF [128]
Hollow Silicon Photolithography followed by
deep-reactive ion etching
150 100 <1 30 ISF [127]
Hollow Silicon Deep-reactive ion etching
followed by wet etching
400 NS NS 30 ISF [132]
Hollow Silicon Deep-reactive ion etching
followed by anisotropic etching
700 260 e 90 ISF [28]
(continued on next page)
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Table 3 (continued )
Type of MN Substrate Material Fabrication Method Length
(mm)
Base
diameter
(mm)
Tip
diameter
(mm)
Hole
diameter
(mm)
Biological
fluid
Ref
Solid Si3N4 coated with Cr/Au Photolithography followed by
reactive ion etching
350 50 50 e ISF [126]
Solid Silicon coated with Fe Photolithography followed by
deep-reactive ion etching
380 NS <1 e ISF [32]
Hollow Silicon Laser micromachining 300e350 150 NS 50 ISF [95,142]
Solid Silicon coated with Au Deep-reactive ion etching
followed by wet etching
600 200 NS e Blood [119]
BISF: brain interstitial fluid; CMRF: curable magnetorheological fluid; COC: cyclic olefin copolymer; CSF: cerebrospinal fluid; f-MWCNT: functionalized multiwalled carbon
nanotubes; IrOx: iridium oxide; ISF: interstitial fluid; NP: nanoparticle; NS: not specified; N-UNCD: nitrogen-incorporated ultrananocrystalline diamond; PCL: poly-
carprolactone; PEDOT: poly(3,4-ethylenedioxythiophene); PEG: polyethylene glycol; PEGDA: poly(ethylene glycol) diacrylate; PET: polyethylene terephthalate; rGO: reduced
graphene oxide; TMPTA: trimethylolpropane ethoxylate triacrylate; UV: ultraviolet radiation.
a Triangular.
b Non-circular.
c MNs were tested in serum aiming at further on-body blood detection.
d Horse.
e Bovine.
f Porous MN.
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and insertion depth of 5 mm).
2.4. Materials and fabrication methods
The material(s) used and the type of MN are also key consid-
erations in the design of MN (bio)sensors, to assure total
compatibility with both the incorporation of the sensing element
and its implementation for transdermal analysis. As observed in
Table 3, the materials generally used to build MNs can be cate-
gorized into three main groups: polymers, metals and silicon.
Most often, polymers are chosen due to their low cost and ease of
manufacture. Thus, a great variety of polymers has been reported
in the literature, including epoxy-based negative photoresists (e.g.
SU8) [16,102e104], acrylate-based polymers (e.g. Eshell)
[37,105e114] or polycarbonate [33,115e118], among others. It is
common practice to modify the polymer fabrication in order to
improve some specific features. For example, the electrical con-
ductivity can be increased by coating polymeric MNs with metals,
metal oxides or alloys such as Au [24,31,33,103,119], Pt/IrOx [118],
Ti/Au [36,120,121] or Cr/Pt [117], Other approaches for conductive
coatings are based on conductive forms of carbon such as carbon
paste [37,105e109,112], carbon fibers [113] or carbon nanotubes
[122]. Although less common, the coating of polymeric MNs can
also have a more specific purpose. For example, Keum et al.
modified polylactic acid MNs with the conducting polymer
poly(3,4-ethylendioxitiophene) to establish a channel layer where
the element of recognition for the analyte (hemin molecules for
nitric oxide) could be placed [123].
In terms of metallic MNs, the most common substrates are Au,
Pt, and W due to their excellent conductivity and biocompatibility.
In addition, although less conductive, stainless steel is commonly
found in the literature because of its high biocompatibility and
lower cost. All of these metals can be further coated to improve
conductivity (if necessary) but also with other goals, as discussed
above for polymer-based MNs. For example, Jin et al. used Pt
nanoparticles and reduced graphene to increase the electro-
catalytic activity of stainless steel MNs towards the detection of
hydrogen peroxide [124]. Jia et al. proposed the use of Ni6MnO8
nanoflakes to improve the surface adherence properties of
stainless-steel MNs by providing a seed layer for further modifi-
cations with the ultimate aim being detection of ascorbic acid [125].
Importantly, MNs fabricated with potentially toxic metals (such as
nickel or nickel alloys) can be coated with metals such as Au or Pd
to improve their biocompatibility [30].8
Silicon, in both its elemental state and as silicon nitride (Si3N4),
is another material widely used in the fabrication of MNs due to its
superior biocompatibility [126]. An interesting feature of hollow
silicon MNs is that they also allow passive extraction of ISF
through capillary actions [127]. Ribet et al. took advantage of this
property in the development of a glucose biosensor, which was
based on the integration of an ultra-miniaturized electrochemical
sensing probe hosted in the bore of a hollow siliconMN (providing
a physical protection during the insertion) and relied upon partial
filling of the MN with ISF through capillary actions before reach-
ing the probe [28].
Concerning the fabrication methods, MNs are generally ob-
tained via one of four different paths depending on how the sub-
strate is formed: mold-filling, lithography, micromachining and
computer assisted polymerization. Mold-filling methods are very
popular due to the versatility that they offer in terms of both MN
shape and substrate nature. By means of this procedure, it is
possible to design and fabricate a general mold with the desired
geometry, and later proceed with the filling of the mold with the
substrate material in liquid state. Despite the predominance of
polymers, Senel et al. have demonstrated that metal-based MNs
can also be produced in this manner using molds filled with
metallic nanoparticles ink embedded in an organic solvent [128].
By convention the molding step is followed by a curing process that
can be performed in different ways depending on the final sub-
strate nature, where UV radiation [31,102,129], heat treatment
[23,24,122,123] and solvent evaporation [130] are the most usual
procedures.
Lithographic methods commonly use bulk materials to etch the
desired shape and dimensions of the MN. The printing is primarily
carried out via photochemical processes [103,131] or thermal
drawing [27]. Magnetorheological drawing lithography [120,121] is
also gradually gaining attention in this field. This method forms the
shape of the MN by handling a magnetic field in a curable mag-
netorheological fluid, which is much simpler compared to tradi-
tional lithography and as an additional advantage does not require
temperature control or light masking. The main drawback of this
method, however, is the limited number of suitable magnetic fluids,
which constitutes a considerable hindrance to versatility.
The third method for MN fabrication is based on micro-
machining, in fact the most commonly used procedure for
metallic MNs (see Table 3). In this method, MNs are obtained from
bulk material by way of highly refined, smooth cutting, with in-
cisions usually but not exclusively made by laser [124,129]. This
technique is however not restricted to metal based MNs; Chua
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fabrication of hollow silicon MNs [95], as an alternative to the
traditional manufacturing process based on deep reactive ion
etching, whereby the bulk Si substrate is brought into the desired
shape by way of attack by ion containing plasma [28,132]. It is
worthy of note that some authors have exploited both micro-
machining and lithography as complementary techniques in order
to create improved MN: the main body of the MN is fabricated by
lithography and micromachining is later employed for final de-
tailing and sharpening [126,133].
The use of computer assisted polymerization has increased in
recent years for MN fabrication. The most common approach in-
volves the polymer E-Shell 200 [37,105e109,112,113] polymerized
by UV radiation. Interestingly, E-Shell 200 is a common material
compatible with 3D printing technology. This polymer provides
structures with clinically desirable properties such as strength,
water-resistance, and biocompatibility, and has therefore been
traditionally employed in a wide variety of medical devices.
3. Electrochemical MN (bio)sensors: useful considerations for
in vitro and ex vivo assays
Table 4 summarizes the most relevant electrochemical MN (bio)
sensors reported over the last decade, according to the approach
established for sensing the analyte. An especial focus has been
placed on the following aspects: sensing element, modification
strategy for introductionwithin the MN substrate, electroanalytical
technique for readout, and analytical parameters presented. In
addition, the calibration media, the target biological fluid and the
analytical application (if any) are collected in Table 4, with a view to
better evaluation of the possible projection/exploitation of each
MN-based invention. In particular, such cases that have demon-
strated in vivo applications are deeper analyzed in Section 4 (see
below).
It is important to highlight that the majority of the figures of
merit reported in the selected papers (Table 4) were obtained in a
buffer medium; in general, experiments carried out in such a ma-
trix overestimate analytical performances when compared to those
carried out in artificial biological fluids [115,131]. More realistic
features are observed in the latter, including biofouling, reduced
sensitivities, and narrower linear ranges of response due to stron-
ger matrix effects, all of which is indeed a closer analogy to real
measurements in ISF or blood. Therefore, the reported analytical
parameters for MN (bio)sensors should be carefully considered
when seeking to interpret any results. In a typical report, the
classical analytical parameters such as limit of detection (LOD),
sensitivity, linear range of response (LRR), selectivity and repro-
ducibility, in the selected medium of buffer or artificial fluid, are
evaluated for MN sensors. However, considering the final in vivo
application for continuous intradermal sensing, other aspects such
as resistance to skin penetration or potential toxicological effects
should also be assessed. Unfortunately, with a few exceptions
which are elaborated upon below, we have found a distinct lack of
such evaluation within the literature.
The procedures and materials utilized to fabricate the MN (bio)
sensors have a strong influence in many transversal aspects related
to the final analytical performance of the device and in vivo suit-
ability. For example, one common strategy for the development of
MN (bio)sensors consists of the external modification of solid MNs,
thus facilitating a good interaction with the analyte [115,131]. But
during skin penetration, the sensing element is entirely exposed to
friction with the skin layers, or even to undesired substances pre-
sent in the skin that can damage or alter the sensor features. One
option to solve this drawback is the employment of an external
water-soluble polymeric layer that protects the sensing element9
frommechanical alteration during skin penetration. Then, the layer
is dissolved in ISF after penetration to allow for direct exposure to
the target [124]. Another strategy used for the preparation of MN
(bio)sensors is based on internal modification of hollow MNs,
which provides a physical protection of the sensing element during
the insertion and limits undesired contact with tissues, therefore
reducing biofouling effect [23,112]. As observed in Table 4, 70.8% of
the reported MN sensors are based on external modification and
only 26.4% on internal modification.
Whatever the strategy used to incorporate the sensing element
to the MN, it is evident that resistance to skin insertion should be
always evaluated prior to any in vivo application to ensure that the
analytical performance of the MN sensor is not affected by the
insertion, nor once inside the skin. Studies of this type have been
proposed through in vitro procedures by use of agarose hydrogel in
contact with artificial ISF to mimic the real skin system [116]. This
approach has been claimed in the literature to be useful in evalu-
ating the resilience of the MN sensor by comparing the calibration
graph before and after insertion in the gel. Such a set upwas used to
confirm that external calibration is suitable for the calculation of ISF
concentrations through transdermal detection, by comparing the
signals acquired through the agarose hydrogel at increasing analyte
concentrations in artificial ISF with external measurements
[105,116]. Another method considers the resilience of the external
calibration after subsequent insertions into animal skin fixed in a
physical support that allows for a contact with artificial ISF inwhich
the analyte concentration can be manually changed, which is un-
doubtedly a closer approach to the real scenario than the use of gel
[34,124,138].
Regarding cytotoxicity studies, it is important to ensure that no
toxic effect is caused by direct contact, leaching, or detachment of
the sensing element. Cytotoxicity assays evaluate cell viability after
exposure to the sensor and/or its different components as
compared to a control group of cells. The effects of direct contact
between the sensor and the cells and of leaching/detachment of
singular components, can be studied by means of different exper-
imental configurations; that is to say, deposition of the sensor/
components directly upon the wells for the former, and for the
latter placement of sensor/components on top of the culture media
(or by use of transwell scaffolds) [143]. Crespo and co-workers
[138,143] performed a cytotoxicity assay with MN sensors for the
determination of potassium based on ion-selective membranes.
Human fibroblasts were used as cell line, and it was found that
valinomycin (the potassium ionophore in the membrane) leached
from the membrane and presented a severe toxic effect (cell
viability of 17.9 ± 2.5%). Cell proliferation tests then demonstrated
that the MN sensor was safe for continuous use over at least 24 h
with no toxic effects. A similar study was reported by Tang et al.
using human umbilical vein endothelial cells to assess the cyto-
toxicity of a MN sensor for the determination of nitric oxide [144].
Several sensor configurations were tested, and no toxic effect was
observed in a 24 h timeframe, with the cell viability being higher
than 90% in all cases. Due to the implanted nature of MN sensors,
immune response should be assessed as well; however, this eval-
uation seems to be routine only for MNs designed for drug delivery
[145]. The immune response studied in these scenarios usually
refers more to the supplied pharmaceutical than the MN itself. In
the case of MN sensors, the immune response is related to the
biocompatibility of the device, which has been already reported in
the literature [146]. Also, some timid efforts have been made in the
direction of evaluating skin inflammation after sensor insertion
[124,140,142,147].
We now consider as a whole the setup needed for the electro-
chemical readout. For a potentiometric or amperometric readout, it
is required a two-electrode (working electrode, WE, and reference
Table 4
Summary of the preparation, analytical performances and applications of MN (bio)sensors reported in the literature in the last decade.
Type of MN Sensing
element
Modification strategy Analytical
technique
Analyte Calibration
media/Target
biological fluid
Analytical parameters Application Ref
Solid GOx External: Electropolymerization in
polydopamine usingmussel protein
as source
Amperometry Glucose NS/ISF LRR: 0e22.2 mM Beagle dogs, cynomolgus
monkey and human
volunteers (ISF)
[134]
Solid GOx External: Polymeric film
(electropolymerization)
Amperometry Glucose PBS/ISF LOD: 0.15 mM
LRR: 0.15e30 mM
Human volunteers (ISF) [102]
Solid GOx External: Enzyme mixed in pre-
polymeric solutions
Amperometry Glucose PBS/ISF LRR: 2e24 mM None [139]
Solid GOx External: Covalent bonding through
MPA
CV Glucose PBS/ISF LRR: 2.8e22.2 mM None [151]
Solid GOx External: Drop-casting in vessel
(during MN formation)
Amperometry Glucose PBS/ISF LOD: 1 mM
LRR: 0e4 mM
None [131]
Solid GOx External: Enzyme mixed in pre-
polymeric solutions
Amperometry Glucose PBS with
MgCl2/ISF
LOD: 0.5 mM
LRR: 0e10 mM
None [152]
Solid GOx External: Covalent bonding through
TMA
Amperometry Glucose PBS/ISF LRR: 2e25 mM Fluidic platform (PBS) [103]
Hollow GOx Internal: Casting of silk-enzyme
mixture on the cavity
Amperometry Glucose Artificial ISF/ISF LRR: 1.7e10.4 mM None [23]
Hollow GOx Internal: Enzyme mixed with
carbon paste
Power density Glucose Artificial ISF/ISF LRR: 0e25 mM None [109]
Hollow GOx Internal: Mechanical dispensing of
cross-linked enzyme
Amperometry Glucose PBS/ISF LRR: 0e13.9 mM Human volunteers (ISF) [28]
Hollow GOx Internal: Enzyme mixed with
carbon paste
Amperometry Glucose PBS/ISF LRR: 2e12 mM None [112]
Solid GOx Non modified: enzymatic reaction
takes place in solution
CV Glucose PBS with
FcCOOH/ISF
LRR: 2e13.5 mM None [31]
Solid GOx External: Covalent bonding to TCA
followed by electropolymerization
Amperometry Glucose PBS/Blood LRR: 0.05e20 mM Finger pricked human
blood
[24]
Solid GOx External: Electrostatic entrapment Amperometry Glucose PBS/Blood LOD: 0.1 mM
LRR: 0e20 mM
Anesthetized mice (blood) [140]
Solid GOx External: Drop-casting Amperometry Glucose PBS/Serum LOD: 260 mM
LRR: 2e12 mM
Spiked fetal bovine serum [36]
Solid inside
hollowa
GOx Internal: Entrapment in polymeric
film
Amperometry Glucose PBS/Serum LOD: 0.1 mM
LRR: 0.1e14 mM
None [114]
Solid GOx External: Dispensing through
nitrogen pulses
Amperometry Glucose PBS/BISF LRR: 0e2.5 mM Brain of anesthetized rats [104]
Solid GDH External: Drop-casting Amperometry Glucose Artificial ISF/ISF LOD: 50 mM
LRR: 0.1e10 mM
Artificial ISF through
chitosan/agarose hydrogel
[115]
Solid- GDH External: Drop-casting Amperometry Glucose Artificial ISF/ISF LOD: 7 mM
LRR: 0.5e5 mM
Artificial ISF through
chitosan/agarose hydrogel
[116]
Solid e External: Electrodeposition of Pt
black
Amperometry Glucose PBS/ISF LRR: 3e20 mM None [32]
Solid e External: Electrodeposition of Pt
black
Amperometry Glucose PBS/Serum LOD: 23 mM
LRR: 1e40 mM
Blood serum [26]
Solid LOx External: Drop-casting Amperometry Lactate Artificial ISF/ISF LOD: 3 mM
LRR: 10e100 mM
Artificial ISF through
chitosan/agarose hydrogel
[116]
Solid LOx External: Drop-casting in vessel
(during MN formation)
Amperometry Lactate PBS/ISF LOD: 1 mM
LRR: 0e1 mM
None [131]
Solid LOx External: Enzyme mixed in pre-
polymeric solutions
Amperometry Lactate PBS with
MgCl2/ISF
LOD: 0.5 mM
LRR: 0e4 mM
None [152]
Solid LOx External: Covalent bonding through
TMA
Amperometry Lactate PBS/ISF LRR: 2e25 mM Fluidic platform (PBS) [103]
Solid LOx External: Drop-casting Amperometry Lactate PBS/ISF LOD: 2.4 mM
LRR: 10e200 mM
Spiked artificial ISF and
spiked human blood
[33]
Hollow LOx Amperometry Lactate PBS/ISF LRR: 2e12 mM None [112]
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Internal: Enzyme mixed with
carbon paste
Hollow LOx Internal: Enzyme mixed with
carbon paste
Amperometry Lactate PBS/ISF LOD: 0.42 mM
LRR: 0.42e8 mM
None [108]
Solid LOx External: Dispensing through
nitrogen pulses
Amperometry Lactate PBS/BISF LRR: 0e3 mM Brain of anesthetized rats [104]
Solid UOx External: Drop-casting Amperometry Uric acid PBS/Serum LOD:4 mM
LRR: 0.1e1.2 mM
Spiked fetal bovine serum [36]
Solid ChOx External: Drop-casting Amperometry Cholesterol PBS/Serum LOD: 440 mM
LRR: 1e12 mM
Spiked fetal bovine serum [36]
Solid inside
hollowa
GluOx Internal: Entrapment in polymeric
film
Amperometry Glutamate Serum/Serum LOD: 21 mM
LRR: 21e140 mM
None [114]
Solid Urease External: Polymeric membrane
(Immersion with stirring)
Amperometry Urea Artificial ISF/ISF LOD: 2.8 mM
LRR: 50e2500 mM
None [128]
Hollow AOx Internal: Polymeric membrane
(drop-casting) on a wire
Amperometry Alcohol Artificial ISF/ISF LRR: 5e80 mM Artificial ISF through mice
skin
[34]
Hollow Tyrosinase Internal: Enzyme mixed with
carbon paste
Amperometry Levodopa Artificial ISF/ISF LOD: 0.25 mM
LRR: 20e300 mM
Artificial ISF through mice
skin
[106]
Hollow e Internal: Non-modified carbon
paste
SWV Levodopa Artificial ISF/ISF LOD: 0.5 mM
LRR: 5e100 mM
Artificial ISF through mice
skin
[106]
Hollow OPH Internal: Enzyme mixed with
carbon paste
SWV MPOx PB/ISF LOD: 4 mM
LRR: 20e180 mM
Mice skin soaked in PB [107]
Hollow OPH Internal: Polymeric membrane
(deposition on surface)
SWV MPOx Artificial ISF/ISF LOD: 10 mM
LRR:10e160 mM
Artificial ISF through
agarose hydrogel
[105]
Hollow e Internal: Non-modified carbon
paste
SWV Fentanyl Artificial ISF/ISF LRR: 10e200 mM None [105]
Hollow e Internal: Non-modified carbon
paste
SWV Norfentanyl Artificial ISF/ISF LRR: 40e400 mM None [105]
Hollow e Internal: Non-modified carbon
paste
SWV Morphine Artificial ISF/ISF LRR: 20e140 mM None [105]
Solid Pt/rGO External: Dip coating followed by
thermal reduction
Amperometry H2O2 PBS/ISF LRR: 0.1e0.6 mM Pigskin tissues soaked in
PBS and mice
[124]
Solid ZnO NWs/Pt External: Sputtering Amperometry H2O2 PBS/ISF LRR: 0e9 mM Anesthetized mice (ISF) [129]
Hollow e Internal: Non-modified carbon
paste
Amperometry H2O2 PBS/ISF LOD: 20 mM
LRR: 20e500 mM
None [108]
Hollow Pd Internal: Electrodeposition CV H2O2 PBS/ISF LOD: 15 mM
LRR: 100e500 mM
None [113]
Solid PANI/MoS2/
PtNP
External: Electropolymerization Amperometry H2O2 PBS/cells
release
LOD: 0.686 mM
LRR: 1e100 mM
Living HeLa cells release [153]
Solid Ni6MnO8 External: Hydrothermal reaction-
calcination
Amperometry Ascorbic acid NaOH/Vitamin
C tablets
LOD: 0.1 mM
LRR: 1e2000 mM
Vitamin C tablets [125]
Solid e External: directly molded with
poly(lactic acid) and CNT composite
DPV Ascorbic acid PBS/ISF LOD: 180 mM
LRR: 0.2e1 mM
Porcine ear skin soaked in
PBS
[122]
Solid e External: Electrochemical
anodization
SWV Uric acid Britton
Robinson
buffer/Blood
LOD: 2.8 mM
LRR: 50e300 mM
Spiked horse blood [130]
Solid N-UNCD External: Microwave plasma
chemical vapor deposition
LSV Uric acid PBS/ISF LRR: 2e200 mM None [141]
Solid N-UNCD External: Microwave plasma
chemical vapor deposition
LSV Dopamine PBS/ISF LRR: 0e30 mM None [141]
Hollow e Internal: Filling with organogel Stripping
voltammetry
Propranolol Physiological
buffer/NS
LOD: 50 nM
LRR: 50e200 nM
Artificial saliva [133]
Hollow Catechol External: Agarose hydrogel (drop-
casting)
Amperometry Tyrosinase Phantom gel/
Melanoma
LRR: 0e4.5 mM Porcine skin loaded with
tyrosine
[37]
Solid PEI/CNT External: Dip-coating Amperometry DNA Tris buffer/NS NS None [126]
Solid FGPC External: Electrodeposition Amperometry NO PBS/Blood LOD: 3.2 nM
LRR: 5e200 nM
Anesthetized rats [144]
Solid Hemin External: Immersion Amperometry NO PBS/Polyps LOD: 1 mM
LRR: 0e16 mM
Mice with and without
melanoma (ISF)
[123]
(continued on next page)
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Table 4 (continued )
Type of MN Sensing
element
Modification strategy Analytical
technique
Analyte Calibration
media/Target
biological fluid
Analytical parameters Application Ref
Solid Gold External: sputtering Amperometry O2 KNO3/Biofilm LOD: 3.4 mM
LRR: 0e0.25 mM
Heterotrophic biofilm
cultivated in a flat-plate
bioreactor
[154]
Hollow e Internal: Nafion membrane on a Pt
wire
CV O2 PBS/
Intramuscular
tissue
LOD: 4.57 mM
LRR: 9e1239 mM
Vascular blood (ex vivo) and
intramuscular tissue
(in vivo)
[149]
Solid Quinone
groups
External: Electrochemical
anodization
SWV pH Britton
Robinson/ISF
NS Tomato skin [35]
Hollow Fast Blue RR Internal: Deposition on carbon
paste
CV pH PBS/ISF LRR: 5e8 None [112]
Solid PANI/MoS2 External: Electropolymerization Potentiometry pH PBS/CSF LRR: 3e9 Rat brain, anesthetized [155]
Solid ZnO External: Sputtering Potentiometry pH Buffer (NS)/CSF
and bladder
LRR: 2e9 CSF and bladder of
anesthetized mice
[73]
Solid IrOx External: Electrodeposition Potentiometry pH Buffer (NS)/
Heart
LRR: 4e8 Explanted rat hearts [136,137]
Solid Valinomycin External: Polymeric membrane
(drop-casting)
Potentiometry Potassium Artificial ISF/ISF LOD: 12.6 mM
LRR: 0.063e63 mM
Artificial ISF through animal
skin
[138]
Hollow Valinomycin In chip: Polymeric membrane
(drop-casting)
Potentiometry Potassium NS/ISF LOD: 2.2 mM
LRR: 0.01e10 mM
Fluidic chip (matrix NS) [111]
Hollow 8-HQS External: Polymeric membrane
(electropolymerization)
Potentiometry Cu (II) pH 5 (NS)/NS LOD: 10 mM
LRR: 10e1000 mM
Spiked tap water and juices [156]
Solid b-lactamase External: Polymeric membrane
(drop-casting)
Potentiometry Penicillin-G Artificial ISF/ISF LRR: 0e4.3 mM None [118]
Solid b-lactamase External: Hydrogel (drop-casting) Potentiometry Penicillin PBS/ISF LOD: 6.8 mM Human volunteers [148]
Solid b-lactamase External: Hydrogel (drop-casting) Potentiometry Phenoxymethylpenicillin Human ECF/
Human ECF
LOD: 0.5 mM Human volunteers [157]
Solid- b-lactamase External: Polymeric membrane
(drop-casting)
Potentiometry Amoxicillin Artificial ISF/ISF LRR: 0e6.9 mM None [118]
Solid b-lactamase External: Polymeric membrane
(drop-casting)
Potentiometry Ceftriaxone Artificial ISF/ISF LRR: 0e110 mM None [118]
Solid VEGF aptamer External: Coating Capacitance VEGF protein Blood serum/
Blood serum
LRR: 0.1e1000 pM None [119]
Solid Biotinylated
BSA
External: Molecular binding Impedance Streptavidin PBS/NS NS Fluidic chip (PBS) [158]
8-HQS: 8-hydroxyquinoline-5-sulfonic acid; AOx: alcohol oxidase; BISF: brain interstitial fluid; BSA: bovine serum albumin; ChOx: cholesterol oxidase; CNT: carbon nanotubes; CV: cyclic voltammetry; ECF: extracellular fluid;
FcCOOH: ferrocene monocarboxylic acid; FGPC: functionalized graphene composite; GA: glutaraldehyde; GDH: glucose dehydrogenase; GluOx: glutamate oxidase; GOx: glucose oxidase; ISF: interstitial fluid; IrOx: iridium
oxide; LOD: limit of detection; LOx: lactate oxidase; LRR: linear range; LSV: linear sweep voltammetry; MPA: 3-mercaptopropionic acid; MPOx: methyl paraoxon; NP: nanoparticles; NS: not specified; N-UNCD: nitrogen
incorporated ultrananocrystalline diamond; NW: nanowire; OPH: organophosphorus hydrolase; PANI: polyaniline; PB: phosphate buffer; PBS: phosphate-buffered saline; PEI: polyethyleneimine rGO: reduced graphene oxide;
TCA: terthiophene carboxylic acid; TMA: thiomalic acid; UOx: uricase; VEGF: vascular endothelial growth factor.
a Solid MN are placed inside hollow MN to facilitate the entrapment of the enzyme.
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of a counter electrode, CE), whereby the WE comprises the sensing
element. The appropriate technology for providing MN-based CE
and RE elements of electrochemical readout has advanced in par-
allel with the development of WEs. Thus, it is possible to integrate
all of the necessary electrodes into separateMNs [138], or all within
one single MN; in the latter case internal modification is evidently
necessary [28].
Upon scrutiny of the literature, it becomes apparent that there is
a trend of utilizing approaches which are well established for
classical electrode formats in preparing the CE and RE. Thus, the RE
may consist of an Ag wire somehow fixed within the MN [23,106]
acting as pseudoreference electrode by providing a potential that is
stable enough to be used in many amperometric sensors. A more
stable potential is provided by Ag/AgCl electrodes prepared as
chlorinated silver wires embedded in hollow MNs, or by some
external modification of theMN such as: i) coating theMNwith Ag/
AgCl ink [124,129]; ii) treatment of a silver-coated MNwith sodium
hypochlorite solution for 30 s [148]; iii) treatment of silver wire or
silver-coated MNs with a saturated solution of FeCl3 [118,133,147];
and iv) anodization of silver wire placed inside the MN in a satu-
rated solution of 3 M KCl for 2 min [149], among others. For the
latter, long-term stability was enhanced by coating the RE with a
Nafion layer, which also provides enhanced biocompatibility and a
non-interfering environment [149].
Although the preparation of these Ag/AgCl REs is simple and
versatile, they are in general rather sensitive to the chloride ion
concentration in the ISF (or any sample), meaning that any signif-
icant deviation between the chloride concentration with respect to
the calibration solution will lead to an error in quantification of the
analyte when a potentiometry readout is used [35], due to a change
in the potential provided by the RE. An enhanced potential stability
may be provided by coating the Ag/AgCl wire or MN with the so-
called reference membrane containing polyvinyl butyral (PVB) as
polymeric matrix with NaCl in saturation levels. An additional
external polyurethane layer has also demonstrated prevention of
chloride leaching from the reference membrane, thereby main-
taining a constant potential independent of the chloride concen-
tration in the sample [138,150]. Concerning the CE, the most
common approaches employed in amperometric measurements
are based on platinum wires inside the MN [34,105,149] or MNs
coated with platinum [124,129].
The final integration of the WE, CE and/or RE can be accom-
plished either in only one or separate MNs. Fig. 4 shows some
representative electrode configurations published in the literature.
A first approach consists of two different MNs (one for the WE and
the other for the RE) for the potentiometric determination of po-
tassium (Fig. 4a) [138]. In this case, both MNs are solid stainless
steel MNs externally modified via drop-casting and fixed in a
polymeric base. A similar approach using three separate MNs (WE,
RE and CE) (Fig. 4b) was employed by Mishra et al. for the amper-
ometric detection of methyl paraoxon [107]: polymeric hollowMNs
were packed with carbon paste (WE and CE) or internally modified
with Ag/AgCl ink (RE). The carbon paste in the WE was further
modified with organophosphorus hydrolase (enzyme). In contrast,
Fig. 4c and d display some configurations illustrating insertion of all
electrodes in one single needle, which is particularly advantageous
in studies where the sensor implantation is considered but
evidently more challenging in terms of fabrication efforts than
providing separate MNs [104,149]. In particular, Fig. 4c displays the
internal design of a MN for the simultaneous detection of glucose
and lactate (with the corresponding enzyme patterner in a Pt lat-
tice) together with a control electrode (same substrate but modi-
fied only with BSA to check non-specific currents), which was used
for in vivo studies in rat brain [104]. One disadvantage here is that13the analyzed fluid should entirely fill the MN in order to provide
reliable measurements for the three analytes, as the CE and RE are
placed on the top of the device. Then, in the system presented in
Fig. 4d, all the electrodes reach the same depth, with the sensor
chip and hand-made electrical connections placed on top of the
base in where the MN containing the electrodes is fixed [28]. In all
the cases, the mission of the MN base is to provide an epidermal
patch in which the requisite MN(s) are fixed for an established
penetration depth. Thus, assemblage of the MN(s) in the base can
be performed either by fixing first the MN(s) and subsequently
tailoring them with the sensing and electrochemical element(s)
[34,107], or by affixing the MN(s) once they are prepared [28]. The
materials most widely used for the MN base are Eshell [37,106] and
PDMS [17,138]. In particular, bases combining the property of
adequate skin adherence with total biocompatibility and flexibility
are desired for optimal adaptation to the subject's movements.
A cursory inspection of Table 4 reveals that the analyte most
widely analyzed with MN sensors is glucose, followed by lactate,
pH, and hydrogen peroxide; alcohol, uric acid, and potassium. MN
sensors seem tomakemore use of ISF than blood analyses, which is
in principle expected according to the philosophy of avoiding blood
tests. Next, we present a detailed discussion of MN (bio)sensors
reported in the last decade collected in Table 4, attending to two
main groups: enzymatic or non-enzymatic sensors. Additionally, a
final section discusses sensor arrays for the simultaneous deter-
mination of various analytes.
3.1. Enzymatic sensors
3.1.1. Glucose detection
The need for a POC tool for the continuous monitoring of dia-
betes incidence in society has meant that continuous glucose
monitoring became the first milestone in the sights of MN sensing
technology development. Clinicians and researchers in the field are
in general agreement on this importance and, accordingly, some
elegant reviews exclusively dedicated to glucose monitoring with
wearable devices and/or MN sensors have been already published
[25,69,78]. Traditionally, glucose has been electrochemically
determined by enzymatic sensors since 1962, when Clark et al.
proposed a successful biosensor based on glucose oxidase (GOx)
[159]. This path has been extensively explored, even with MN
sensors, resulting in a considerable number of publications and the
release of a few commercial devices, which will be discussed in the
last section of this review. As observed in Table 4, different strate-
gies for GOx immobilization on the MN substrate have been
investigated with regards to amperometric glucose detection.
From an analytical point of view, one key parameter that should
be assessed to guarantee continuous glucose monitoring within the
expected physiological range is the LRR. This concept can indeed be
extended to any other analyte. Measurements obtained through
skin insertion are not compatible with any type of sample treat-
ment or dilution, being purely on-body measurements from tem-
porary sensors implanted through and/or over the skin, and
therefore, the obtained LRR must cover both normal and abnormal
glucose levels (without any pre-treatment consideration). Normal
glucose levels in blood are usually between 3.3 mM and 5.5 mM
during fasting periods and up to 7.8 mMwithin 2 h of eating. Blood
glucose levels of 8.8 mM are considered high and in extreme cases
values of 20 mM have been reported. In contrast, glucose levels in
ISF are not as well-known as those in blood, although some studies
have assured a correlation between values found in the two fluids
when the subject's body is in equilibrium (i.e. no net tendency to
change) [160,161]. However, rapid changes in body glucose levels
do not manifest in ISF as fast as in blood, due to the glucose diffu-
sion from plasma to ISF as defined in previous sections [28].
Fig. 4. Examples of modification strategies for MN sensors aiming for in vivo analysis. a) Two separate MN (WE and RE) externally modified for the potentiometric determination of
potassium (Reproduced with permission from Ref. [138]), b) Three separate MN (WE, RE and CE) internally modified for the amperometric determination of methyl paraoxon
(Reproduced with permission from Ref. [107]), c) Single MN containing 2 WEs and 1 control electrode distributed along its length for the simultaneous amperometric determination
of glucose and lactate (Reproduced with permission from Ref. [104]), d) Single MN containing 3 electrodes (WE, RE and CE) for the amperometric determination of glucose
(Reproduced with permission from Ref. [28]).
J.J. García-Guzman, C. Perez-Rafols, M. Cuartero et al. Trends in Analytical Chemistry 135 (2021) 116148Assuming the same glucose concentration range in blood and ISF,
adequate LRRs have been achieved with different MN sensors, with
the majority of examples making use of external polymeric layers
(such as Nafion or polyurethane) to provide appropriate analyte
diffusion into the enzyme element, as well as to control the
response of the biosensor towards certain interferants (such as
ascorbic and uric acid) [16,103].
Other factors that should be considered are enzyme stability,
overall lifetime of the sensor, and the effect of some physiological
parameters prone to change during in vivo measurements (e.g.,
temperature, pH, conductivity, etc). Unfortunately, as far as we have
been able to ascertain in the reported literature, these prospects are
not rigorously evaluated at the in vitro stage despite being crucial to
the achievement of in vivo applications and reliable clinical devices.
Firstly, the developed MN biosensors should be stable for long
periods of time under well-defined (and easy to achieve) storage
conditions.While enzyme stability seems to be somehow improved
or controlled with an appropriate immobilization method (i.e.
adsorption in layer architectures [140], covalent bonding [24],
cross-linking and physical entrapment [140,158], as can be seen in
Table 4)[162], the optimization of storage conditions is also
essential to maximize the lifetime of theMN biosensor preparation.
Regarding the effect of changes in the initial composition of the
physiological fluid under study during in vivo (on-body) measure-
ments, it is well-known that drastic changes in pH, temperature
and sometimes conductivity affect the response of any enzyme,
natural or engineered. Accordingly, the effect of these parameters
in the biosensor response must be addressed, not only for GOx
sensors, but for any other (bio)sensor exposed to the effects of these
conditions. It would be convenient tomeasure at least pH and Talso
with MN based sensors, in order to provide an algorithm for the
dynamic correction of the (bio)sensor response according to
localised changes, in order to maximize the accuracy of the14developed device. To the best of our knowledge, correction of this
sort is lacking in the literature. As a guide for the reader, our
research group has been recently working in this direction in the
development of a wearable epidermal patch for glucose detection
in sweat [12,163]. Similar strategies would undoubtedly benefit the
MN sensor field towards trustworthy clinical POC solutions.
In general, traditional glucometers using human blood (“finger
pricked”) serve to evaluate the accuracy of the results provided by
MNs reported for glucose analysis in ISF; evidently this validation
only holds when assuming equal concentration of glucose in both
fluids, taking into consideration the delay caused by diffusion from
blood to ISF. Kim et al. developed a glucose MN biosensor by means
of the following procedure [24]: a connector, insulator and spacer
(with micro-holes) were joined prior to placing a MN mold on top
and polymerizing the MNs. Subsequently a gold layer was elec-
trodeposited covering all theMNs (WE, RE and CE), and theWEwas
externally modified by covalent bonding of GOx to a monomer
(terthiophene) by a carbodiimide/N-hydroxysuccinimide reaction
via CV onto the gold coatedMN array. Finally, the whole sensor was
coated with a Nafion layer. Amperometry in 0.1 M PBS (pH 7.4) was
used for glucose calibration, achieving a LRR of 0.05e20 mM. An
interesting feature of this work is the integration of a miniaturized
portable potentiostat and a reusable wireless transmitter that can
send the measured values to a mobile phone via Bluetooth. These
elements were assembled in a transmitter with the MN array
located in the lower part and placed on top of a measuring cell
(Fig. 5). The incorporation of these two elements is fundamental in
taking steps towards real market applications of continuous
glucose monitoring. Although this paper presented a high level of
integration, the performance of the entire device was tested only
ex vivo with blood samples subjected to a dilution factor of 100.
Although the LRR provided by the MN sensors was sufficient to
cover blood glucose levels, this dilution was necessary to increase
Fig. 5. Transmitter consisting of (A) top cover with an on/off button, (B) integrated transmitter modules, (C) lithium-ion polymer battery and (D) bottom cover with the micro-
needle. (E) Assembled transmitter with 33 mm diameter and 7.5 mm height coupled to the measuring cell. Reproduced with permission from Ref. [146]).
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the MN biosensor was immersed. The obtained glucose concen-
tration in the samples was compared with a commercial glucose
monitoring equipment, showing good correspondence.
It is of note that GOx is not unique as an available enzyme for the
development of glucose biosensors; glucose dehydrogenase (GDH)
has also been reported for this purpose (see Table 4). Bollella et al.
used GDH and 6-(ferrocenyl)hexanethiol (redox mediator)
embedded within a goldMN array with the aim of enhanced sensor
selectivity [115]. Indeed, selectivity studies showed that D-fructose,
D-mannitol, D-galactose and ascorbic acid did not show a significant
response (being lower than 10% of the signal registered for glucose
at equivalent concentrations). In terms of stability, the sensor
presented a rather stable signal for 30 days (with 80% of the initial
signal being recorded after this period). The calibration was per-
formed in artificial ISF and the LOD and LRR obtained were 50 mM
and 0.1e10 mM respectively, which are acceptable for both healthy
and diabetic samples. The influence of the temperature and pH on
the biosensor response was also studied, achieving optimal results
at pH 7 and 35C. However, this kind of optimization is not very
useful in the case of MN sensors because neither pH nor temper-
ature can be adjusted during in vivo assays. However, these data
could be used for further correction of the sensor response, as
suggested in the previous section. Also, sensor performance was by
insertion in chitosan/agarose hydrogel embedded with ISF as a
skin-mimicking model. Two different glucose concentrations were
tested simulating low and high glucose levels (4 and 8 mM),
demonstrating that the insertion did not hinder the sensor
performance.
3.1.2. Detection of other analytes
After glucose (according to Table 4) the molecule most
frequently analyzed by MN biosensors is lactate. Blood lactate
levels range from 0.60e0.96 mM in basal conditions [87] to
12e25 mM during physical exercise or in abnormal body situations
such as cardiac diseases [164]. Importantly, most of the reported15MN biosensors cannot reach the required LRR (ca. 0.5e25 mM,
Table 4) for the reliable detection of lactate in blood and also in ISF,
since similar levels are expected in both fluids. While the detection
of basal conditions is generally quite facile, saturation problems
hinder the determination of higher concentrations, with the upper
limit of linearity reaching 8e12 mM in best-case scenarios (see
Table 4) [108,112]. Note that this problematic is not a particularity of
MN lactate biosensors, but instead constitutes a limitation for any
amperometric detection of lactate with enzymatic sensor [165].
Further fundamental research is undeniably still needed in this
direction for any subsequent application to MN technology.
Commonly, lactate sensors are based on lactate oxidase (LOx),
which oxidises lactate with the release of hydrogen peroxide that is
then detected through a redox mediator. This is the strategy fol-
lowed by Bollella et al., who externally modified an array of gold
MNs, immobilizing LOx (by drop-casting) on a nanocomposite
surface (Au-multiwalled carbon nanotubes) that contained meth-
ylene blue as redoxmediator [33]. The calibrationwas performed in
amperometry mode in 50 mM PBS (pH 7.4), achieving a LOD of
2.4 mM and LRR of 10e200 mM, still very far from the required
concentration range. Stability tests were conducted by carrying out
20measurements of a 0.2 mM lactate solution daily, with storage of
the electrode in the fridge when not in use. The sensor presented
ca.10% loss of the initial response after 30 days. No appreciable
interference was observed in the presence of ascorbic acid, uric
acid, or glucose. The analytical performance of the sensor was
tested in artificial ISF and human serum samples, obtaining an even
narrower LRR and lower sensitivities in these fluids. As yet, this MN
lactate biosensor remains rather far from successful implementa-
tion in vivo studies despite the extraordinary reported lifetime.
More modest efforts have been invested in urea sensing
(Table 4), which is considered as a biomarker for kidney and heart
disorders as well as renal diseases, among others [166]. Normal
concentrations of urea range from 2.5 mM to 7.5 mM and lower
levels can be found in patients with hepatotoxicity (usually be-
tween 1.9 mM and 2.8 mM) [167]. Importantly, urea concentration
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healthy person, which is very valuable in the search for further
disease correlations [168]. Senel et al. developed an enzymatic MN
urea sensor employing urease in a matrix of poly(glycidyl
methacrylate-co-vinylferrocene) [128]. The attachment of urease in
the MN was carried out by bringing into contact the enzyme dis-
solved in 10 mM PBS (pH 7.4) with the MN (previously drop-cast
with polymer layer) over a period of 24 h. Calibration was per-
formed by amperometry in artificial ISF background, and also
through agarose hydrogel (phantom gel) to mimic the skin model.
The LRR in both cases was the same (50e2500 mM), being
adequately low to detect normal concentrations of urea in blood/
ISF, whereas lower sensitivities were observed when calibration
was performed through the phantom gel (31 nA mM1 vs
52 nA mM1 without the gel). The authors speculated that this
decrease in sensitivity is likely attributed to the slow diffusion of
urea through the hydrogel matrix. This conclusion indeed coincides
with our own studies with MNs inserted in animal skin for potas-
sium detection [138]. We demonstrated that when potassium ion
concentration was increased in artificial ISF in contact with animal
skin inwhichMNswere inserted, the final potassium concentration
reached inside the skin (and therefore read by the MNs) were al-
ways lower than that concentration in the external ISF. This was
determined to be a result of the diffusion and distribution of the
ion, driven by the concentration gradient at the skin-artificial ISF
interface, as was demonstrated by regular diffusion experiments
[138]. Although it is obvious that the sensor reported by Senel et al.
is not yet suitable for in vivo assays, this work deserves great praise
for innovation in urea sensing via MNs [128].
An alcohol MN biosensor was introduced by Mohan et al.
through the immobilization of alcohol oxidase (AOx) in a chitosan
layer covered by Nafion and integrated inside a hollow polymeric
MN [34]. The amperometric calibration was performed in 0.1 M PB
(pH 7) and artificial ISF. The resulting LRR ranged from 0 to 80 mM
in both media, which is wide enough to detect the legal limits for
driving established by many countries. Interferent studies for uric
acid, acetaminophen (paracetamol), and ascorbic acid were also
accomplished. A signal variation of only 6% was observed during
the assays using a relatively high concentration (100 mM) of such
compounds. Ex vivo assays were performed by inserting the MN
sensors in a layer of mouse skin and immersing it in artificial ISF. No
structural or mechanical damage was observed in the MNs after
multiple insertions and the analytical performance of the enzy-
matic layer was not affected by the insertion and/or biofouling
either. It was claimed in the paper that the polymeric cover pro-
tected the sensor hosted inside, making it suitable for alcohol
monitoring in ex vivo conditions. Certainly, the monitoring of ISF
alcohol is a very interesting topic that could help to prevent car
accidents, with sensors communicating the results directly to a
smart interface placed within the car. However, it should be noted
that less invasive approaches to this problem, such as sweat sensors
in the gearshift and facial monitoring systems among others, are
already being considered by some of the major automobile com-
panies [169].
A similar approach was applied by Goud et al. for levodopa
monitoring in ISF [106]. At the time of writing, levodopa is one of
the most effective drugs for the treatment of Parkinson's disease
but the dose needs to be carefully controlled depending on the
symptoms of the patient [170]. Thus, if the amount supplied is too
low, symptoms such as Parkinsonism and anxiety/depression may
appear. Contrarily, high amounts can provoke dyskinesias, psy-
chosis, etc. Therefore, a more reliable procedure guided by sensors
could lead to an improvement in the health and quality of life of
patients suffering from Parkinson's disease. The approach reported
by Goud et al. uses tyrosinase to convert levodopa into16dopaquinone in an electrochemically controlled reaction [106].
Tyrosinase was mixed with a carbon paste and then, hollow MNs
were filled with the resulting mixture and externally covered with
a protective Nafion layer. The enzymatic sensor was calibrated in
artificial ISF, obtaining 0.25 mM and 0.25e3.0 mM as LOD and LRR
respectively. Phantom gel based as well as ex vivo mouse skin as-
says were performed in artificial ISF media, obtaining comparable
results in the LRR before and after the insertion of the MNs. Simi-
larly to the work presented by Mohan et al., the mouseskin layer
was pierced by the MNs with subsequent immersion in artificial ISF
[34]. Also, with this set up, biofouling issues were evaluated using
common proteins found in ISF such as albumin and g -globulin,
observing a relatively stable signal with ca.11e14% of signal change
(i.e. drift) over 2 h. The observed relatively low susceptibility to
biofouling was attributed to the external Nafion layer.
Amperometry remains the most popular electrochemical tech-
nique in enzymatic sensors, however potentiometric approaches
can also be used for biomolecule and drug detection. In this di-
rection, Gowers et al. developed a potentiometric MN sensor for the
determination of b-lactam antibiotics (such as penicillin G) [148].
As a general approach, monitoring of antibiotics with MN (bio)
sensors may provide the needed information to dynamically adjust
the dose for the patient. The principle of the sensor has its roots in
the b-lactamase hydrolyzation of b-lactam antibiotics, which in-
volves changes of pH in the medium. Therefore, a pH sensor can be
used for the indirect determination of the antibiotic concentration.
To fabricate the pH sensor, the authors deposited a film of IrOx as
pH sensitive layer on the surface of a gold-covered polycarbonate
MN array and then, the MNs were coated with a hydrogel con-
taining the enzyme and an outer layer of poly(ethylenimine), which
seems to enhance the stability of the sensor. Finally, the MNs were
sterilized by exposure to gamma radiation.
Penicillin G calibration was performed in 10 mM PBS, resulting
in a LOD of 6.8 mM, which is not low enough for most clinical
purposes: peak serum levels after a 500 mg dose have been re-
ported to be 4.4e8.1 mM and 1.8e3.0 mM for the total and free
penicillin G respectively [171]. Stability studies performed for 14
days showed an initial decrease in the sensitivity during days 1e3
and a stabilization of the signal afterwards. However, it seems that
the sterilization procedure negatively affects the observed sensi-
tivity, this fact was also pointed out by other authors [102]. Inter-
estingly, preliminary in vivo assays involving a healthy human
volunteer were also accomplished. A calibration was performed
before and after the in vivo insertion, and the similar values ob-
tained demonstrated that the sensing layers were not affected by
the in vivo measurements. Furthermore, promising results were
achieved through the comparison of the values obtained with ISF
collected through microdialysis measurements (requiring subcu-
taneous insertion of microdialysis probes) and discrete blood
samples, observing the same qualitative trend over time in each
case. A key aspect is the successful monitoring of penicillin in both
ex vivo (human skin) and in vivo conditions. Nevertheless, the
concentrations found were very similar to the LOD of the MN
sensor and thus, further fundamental studies would be necessary
to push down this limit in order to provide enhanced accuracy of
the results, as the authors highlighted in the conclusions of their
paper.
3.2. Non-enzymatic sensors
Non-enzymatic MN sensors have been reported for the detec-
tion of biomolecules, drugs, pH, ions, hydrogen peroxide, oxygen,
and nitric oxide (see Table 4). In particular, some of these examples
have sought to resolve the drawbacks reported for enzymatic MN
glucose sensors [26,32], arising from the presence of the biological
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easily affected by temperature, pH, and humidity), complex fabri-
cation procedures, oxygen limitation, economical affordability of
the entire sensor and/or lack of reproducibility in sensitivity [172].
In addition, the easier fabrication process of non-enzymatic sensors
could facilitate mass-production of MN sensors and their higher
stability would allow for implantable probes. Besides that, accept-
able analytical parameters have been reported for in vitro assays,
such as a wide enough linear response for glucose detection in
undiluted blood and ISF, with no in vivo analysis being attempted
yet [26,32]. The detection principle omits the use of any enzyme,
and the direct oxidation of glucose on platinum-based nano-
materials is used instead.
The detection of hydrogen peroxide, which is involved in many
biological processes and may provide information regarding cell or
DNA damage, has also been reported for non-enzymatic MNs using
amperometry or cyclic voltammetry (see Table 4). The sensor
fabrication procedure is commonly based on the use of noble
metals (such as platinum and palladium), given the electrocatalytic
activity for redox reactions of hydrogen peroxide presented by
these metals [124]. Hybrid nanomaterials in which 2D graphene or
molybdenum disulfide are used to immobilize NPs of precious
metal have been proposed to enhance the MN sensitivity and
analytical performance [124,153]. However, for the implementation
of MN sensors in continuous H2O2 monitoring, the LRR presented
by state-of-the-art MN sensors ought to be wider still, especially
regarding the lower limit (and the related limit of detection).
Notably, most of the reported MN sensors are not suitable for
quantification of cytotoxic levels (50 mM) [173]. Sensors of this
kind can be used for the indirect determination of biomolecules
whose oxidations are catalyzed by oxidases (e.g., glucose, lactate,
uric acid or cholesterol), thereby avoiding the use of Prussian blue
or other redox mediators [174].
Amperometric and voltammetric MN sensors have been pro-
posed for the determination of biomolecules commonly present in
ISF and blood, including ascorbic acid [122,125], uric acid [130,141]
and dopamine [141], as well as potential disease biomarkers such as
nitric oxide [123,144]. Because most of these biomolecules present
similar anodic potentials, voltammetric sensors seem to present
greater discrimination capabilities than amperometric ones, but
still the presence of overlapping peaks may hinder the selective
determination of a given analyte. On the other hand, MN sensors for
nitric oxide detection are slightly further advanced towards in vivo
analysis. For example, Keum et al. reported on polycaprolactone
needles functionalized with hemin that are able to differentiate
between melanoma tissues and normal ones [123]. Other inter-
esting applications are the label-free quantification of DNA [126]
and the monitoring of specific drugs, such as propranolol [133] or
fentanyl [105].
Regarding potentiometric detection, some successful examples
used MNs based on metal oxides [73,136,137] or pH-sensitive
conducting polymers [155] for the determination of pH, and ion-
selective membranes for the determination of potassium [111,138]
and copper [156]. In particular for pH sensing, the work by Zuliani
et al. used iridium oxide electrodeposited on an array of plastic
MNs, enabling a mapping of pH distribution in soft and heteroge-
neous samples (e.g. tissues and organs) [137]. The authors stressed
that the sensor was not affected by proteins such as albumin but
some interference was noted with CaCl2 and MgCl2. The sensor was
applied to cardiac tissue (rat heart) during ex vivo assays. pH was
measured during cycles of ischemia/reperfusion events and a pH
mapwas constructed using the values obtained from each needle of
the array. However, the selectivity of the MN-based pH sensor must
needs be improved, and the insertion protocol (in the tissue/organ)
must be revised to avoid artifacts during the measurements due to17movement of the organs, as the authors indeed indicated in that
paper.
In vivo potentiometric applications have been reported only for
pH monitoring in rats, specifically in brain and bladder [73,155],
despite the determination of other ions being also relevant because
electrolyte imbalances are associated with diverse dysfunctions
and diseases, such as hypo- and hyper-natremia, hypo- and hyper-
kalemia, heart disorders, muscle activity deterioration, distur-
bances in cerebral metabolism and cystic fibrosis [48]. In this
context, Sharifian et al. introduced a MN sensor for the determi-
nation of copper [156], which is important in specific nutritional
and medicinal contexts due to its importance as cofactor for met-
alloproteins that modulate protein functions and/or produce crit-
ical enzymes for life [175]. Steel MNs were coated by a layer of
polypyrrole doped with 8-hydroxyquinoline-5-sulfonic acid (PPy/
8-HQS) by means of electropolymerization using the MN as sub-
strate. Seemingly, PPy/8-HQS presents a significant selectivity to-
wards Cu(II) ions. Thus, a LRR from 105 to 101 M was observed
during the calibrations at pH 5, which is rather far from the
required physiological pH range to translate the concept into in vivo
measurements. In any event, the authors specifically used the MN
sensor for environmental and food applications (spiked tap water
and fruit juice samples).
Our group recently developed a potentiometric MN-based
sensor using a multilayer structure ending in a potassium-
selective membrane (i.e. carbon þ transducer þ potassium-selec-
tive membrane) [138]. Interestingly, the recipe for the external
modification of the solid MN is analogous to regular werable ion
sensors for sweat [163]. First, it was demonstrated that the use of a
nanomaterial (functionalized multiwalled carbon nanotubes) as
the ion-to-electron transducer layer provided a better stability,
having a midterm drift of 1.4 ± 0.14 and 0.2 ± 0.08 mV h1 for the
sensors respectively without and with the transducer. Second, the
observed LRR in artificial ISF (from 104.2 to 101.2 M) allowed for
clear distinction between healthy and harmful levels of potassium
in ISF. Then, no significant interference from the ISF matrix com-
pounds (cations, glucose and urea) was incurred. In addition,
ex vivo assays were performed by piercing a piece of chicken skin
with both the WE and RE, immersing the whole system in artificial
ISF solution, and then monitoring potassium concentration inside
the skin after several additions of potassium into the ISF medium.
Finally, cytotoxicity assays were performed by using immunofluo-
rescence staining of two biomarkers: Hoechst for the nucleus of the
fixed cells and KI-67 for proliferation behavior of the fibroblasts.
The results proved that it is possible to use the sensor in continuous
operation over the course of at least 24 h without inducing any risk
for the patient.
3.3. Multi-analyte detection
When facing the issue of detection of multiple analytes, the
typical means of address involves incorporating several WEs in
combination in the MN array, each WE displaying specificity to-
wards a given analyte. Then, the RE and CE can be used individually
for each WE or all in conjunction, depending on the readout re-
quirements. Interestingly, the option of combining both potenti-
ometry and amperometry readouts in the same wearable device
has been already demonstrated in the literature [176]. The reader
should note that the twin approaches of miniaturization of the
required instrumentation and wireless transmission of the outputs
have been extensively investigated in the field of wearable elec-
trochemical sensors, but not yet fully applied to MN-based devices.
Thus, in the majority of the inspected works the authors limit the
information provided to the connections between the readout
electronics and the MN. This has been primarily achieved with
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with gold contacts together with silver epoxy [148]. However, there
are some exceptions where the electronic part is more detailed.
Kim et al. described their electronic part as a union of a micro
controller unit, a miniaturized potentiostat, an analog/digital con-
verter, a Bluetooth and a flexible lithium-ion polymer battery [134].
It is fairly self-evident that the grade of complexity of the sensing
architecture increases with the increasing number of analytes.
Within the scope of MN sensors, multi-analyte detection has
been predominantly applied to the simultaneous determination of
glucose and lactate by way of enzymatic sensors [103,104,116], and
several applications and electrode configurations have been re-
ported to date (Table 4). Bollella et al. developed an array of
externally modified MNs including one WE for lactate and one for
glucose, RE (silver) and CE (gold) [116]. In vitro simulation of ISF
monitoring was carried out by measuring glucose and lactate in
artificial ISF through a chitosan/agarose hydrogel in flow condi-
tions, demonstrating that the developed array is able to provide a
stable signal for long periods of time (110 h). However, the clinical
range expected for lactate lies outside of the observed LRR
(10e100 mM) and furthermore, current density values for glucose
did not correlate to the calibration graph accomplished in artificial
ISF (not using the hydrogel setup). Unfortunately, the authors did
not provide an explanation for this fatal issue.
A similar MN array, with two enzymatic WEs (external modifi-
cation) sharing the CE (Ag/AgCl) and RE (Ag/AgCl) was reported by
Trzebinski et al. for the simultaneous detection of glucose and
lactate [103]. An epoxy-polyurethane membrane was deposited as
the external layer of both WEs to prolong the LRR and decrease
possible interferences by means of restrictive diffusion processes.
Thus, LRR of 2e25 mM was reported for both glucose and lactate,
although a closer look at the reported data reveals poor linearity for
the lactate sensor, with an exponential trend in the calibration
curve indicating saturation at a lower concentration than that re-
ported in the upper limit of the LRR.
A single-needle approach was reported by Vasylieva et al. for
the simultaneous determination of glucose and lactate in rat brain
[104]: three different electrodes (for glucose, lactate, and control)
were located inside a 3-mm long MN (Fig. 4b). The control elec-
trode (BSA modified) was included in the MN to detect non-
specific variations of the recorded current, which were later
subtracted from the glucose and lactate signals. Importantly, the
authors investigated cross-talking effects in the glucose and
lactate sensors originating from the close proximity of the elec-
trodes and/or the diffusion of generated hydrogen peroxide be-
tween them. As this may contribute to important errors in the
calculation of the concentration of both analytes, the authors
proposed placing the control electrode with BSA between the
lactate and glucose sensors, maximizing the distance between
them whilst also recording any possible non-specific current. In
addition, micro-wells were introduced into the electrode sur-
rounding to create a steric barrier against hydrogen peroxide
diffusion out of the well.
Apart from glucose and lactate detection, other groups of ana-
lytes have also been explored with MN sensors (Table 4). Gao et al.
reported on the simultaneous analysis of glucose, uric acid and
cholesterol towards clinical information about metabolite imbal-
ances involved in hypertension, hyperglycemia, hyperlipidemia
and hyperuricemia diseases [36]. The three WEs were fabricated by
the external modification of Au/Ti coated MNs using a layer-by-
layer approach including polyaniline (PANI), Pt nanoparticles and
the corresponding enzyme (GOx, uricase (UOx) or cholesterol oxi-
dase (ChOx)). Seemingly, the introduction of PANI and Pt18nanoparticles enhanced both the conductivity and catalytic activity
of the MN. In vitromeasurements were performedwith a shared RE
(Ag/AgCl) and CE (Pt), showing a LRR of 2e12 mM, 0.1e1.2 mM and
1e12 mM for glucose, uric acid and cholesterol respectively, all of
which cover the corresponding physiological ranges in blood. No
interferences were observed among these three analytes or from
other common metabolites, such as ascorbic acid or bilirubin. The
MNs were controlled by a programmed and portable multi-channel
electrochemical analyzer that allowed the control of each of the
electrochemical measurements from a tactile screen.
Mishra et al. [105] have recently reported an array of voltam-
metric sensors based on hollow MNs filled with carbon paste that
is able to discriminate between episodes of opioid overdose and
nerve agent poisoning. A non-enzymatic MN sensor is used to
detect fentanyl (the dominant synthetic opioid) based on the
oxidative dealkylation of its piperidine tertiary amine group,
which results in a voltammetric peak at ca. 0.7 V. Then, a second
electrode is modified with organophosphorus hydrolase (OPH) to
detect methyl paraoxon (MPOx). This last detection is based on
the indirect determination of the p-nitrophenol generated
through the hydrolyzation of MPOx by OPH, with a LOD of 10 mM.
The fentanyl sensor presented a LRR of 10e200 mM, but also, it
detects morphine (20e140 mM) and norfentanyl (40e400 mM),
which is the primary metabolic product of fentanyl. The
discrimination between fentanyl and these other two compounds
was made possible by their distinct profiles in square wave vol-
tammetry. On the other hand, it was demonstrated that the LOD
for fentanyl could be lowered down to 50 nM through the incor-
poration of CNTs into the carbon paste and the addition of a hybrid
film comprising Au nanoparticles and electrochemically reduced
graphene oxide. This decrease in the LOD is particularly important
because blood fentanyl levels above 60 nM may cause fatal effects
in patients [105]. This work uses an approach of separate MNs for
each electrode with both WEs being connected to the same RE
(Ag/AgCl wire inserted inside the MN) and CE (non-modified
carbon paste), which seems to help eliminate cross-talking effects.
The potential of the developed array for further in vivo measure-
ments was evaluated by means of an agarose tissue-mimicking
phantom gel and artificial ISF. Well-defined voltammetric peaks
that increased linearly with the analyte concentration were ach-
ieved, although noticeable differences in peak potential and in-
tensity were found compared to regular calibration curves.
Interestingly, other devices have been reported for multi-
analyte sensing with MNs that are not the sensing element itself,
but still playing an important role in the entire conception of the
analysis. For example, Miller et al. proposed the simultaneous
determination of glucose, lactate and pH using hollowMNs to drain
ISF from the subject leading to external sensors located along a
platform based on a flexible flat cable [112]. This device demon-
strated adequate in vitro performance, achieving the LRR of
2e12 mM for glucose and lactate in a pH range between 5 and 8.
Unfortunately, the authors did not demonstrate any implementa-
tion in in vivo ISF measurements.
4. Beyond the lab: challenges in real life applications and
current market state
Among all the MN (bio)sensors reported in the literature in the
last decade, in vivo applicability has been achieved in only a few
cases [16,28,134,142]. In the vast majority of the published papers,
the MN sensing technology remains at the laboratory scale
(equivalent to TRL3, Technological Readiness Level, as defined in
Horizon 2020 European guidelines), approximately halfway
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This last section of the review includes a discussion of the most
advanced sensors that have gone through this crucial step of
technological readiness; daring to perform in vivo measurements.
An overview of the current market of monitoring with MN sensors
is presented as well.
4.1. Establishing an adequate MN scheme
Table 5 lists MN (bio)sensors that have been applied to in vivo
studies essentially involving the detection of glucose
[16,28,95,134,142], lactate [104], hydrogen peroxide [124], peni-
cillin [148], methyl paraoxon [107] and nitric oxide in ISF [123];
phenoxymethylpenicillin in ECF [157], glucose (with surgery) [140]
and oxygen in blood [149]; and pH in CSF, heart and bladder, mainly
in humans, rats and mice [73,137]. Attending first to the measuring
scheme, two main trends are found among the collected in vivo
studies, which are outlined in Fig. 6: direct transdermal detection,
or analyte extraction through the MNs coupled to different
analytical approaches.
The most common path involves the direct insertion of a MN
patch in which the modified MNs are inserted and fixed at the
required length to reach the fluid to be analyzed (Fig. 6a). MNs can
be modified externally (Fig. 6b) or internally (Fig. 6c) with different
approaches before or after being embedded in the patch. The se-
lection of this procedure depends on the entire process of the
sensor preparation and its compatibility with the patch/base ma-
terial. Evidently, the final architecture must assure that the MNs
resist transdermal penetration.
In this sense, several approaches have been exploited for the
modification of MNs already embedded in the patch. Rawson et al.
metallized polycarbonate MN arrays using chromium and a layer of
gold and silver, respectively, for theWE and RE [157]. Subsequently,
the WE was modified with the sensing element (b-lactamase).
Samavat et al. used tetrathiafulvalene and GOx on the WEs of the
MN array by spray deposition [16]. Kim et al. screen-printed carbon
and Ag/AgCl layers as WE and RE in polyethylene terephthalate
(PET) MNs [134]. Afterwards, an electron transfer mediator and the
recognition element were electrodeposited, namely ferrocene car-
boxylic acid and GOx respectively. Finally, in order to protect and
improve the robustness of the sensor, a mussel protein (dopa-
incorporated foot protein-3) was electrodeposited on top of the
WE. Jin et al. also proposed the protection of the MN sensor during
insertion [124]. The authors employed Pt nanoparticles with
reduced graphene deposited by dip coating to prepare the WE,
followed by protection of the sensor using a water-soluble layer of
polyvinylpyrrolidone (PVP). This layer ensured a safe insertion for
the sensor, and a proper determination of hydrogen peroxide after
the dissolution of the PVP in the subcutaneous ISF. This kind of
protection approaches results interesting for MN (bio)sensors
prepared as per external modification (Fig. 6b).
In contrast, greater protection during the insertion can be
achieved by hosting the sensing element inside hollow MNs
(Fig. 6c). Once transdermal penetration is completed, two options
are possible: (i) the biological fluid will flood the inner part of the
MN closing the electrochemical cell circuit for adequate readout;
and (ii) the sensing element is located at the tip of the needle and
is somehow in direct contact with the fluid. For example, Ribet
et al. presented hollow silicon MNs that were employed as plat-
form to include the electrodes inside their lumen (the bore at the
tip of the MN) [28]. The WE and RE were made by deposition of a
platinum and iridium layer respectively, following a functionali-
zation of the WE with the sensing element (mixture of GOx, BSA
and glutaraldehyde) by drop-casting means. Mishra et al. pro-
posed filling the inner part of hollow MN with conductive inks:19carbon and Ag/AgCl for the WE and RE respectively [107]. Then,
the corresponding enzyme mixture for MPOx detection was
deposited by drop-casting. In another approach, Vasylieva et al.
used Silicon/SU8 MN to prepare MNs with micro-well structure,
which were filled with GOx and LOx mixed with crosslinking
agents, namely glutaraldehyde and poly (ethylene glycol) digly-
cidyl ether (PEGDE) [104].
MN patches have also been reported for off-bodymeasurements
based on using the MNs as fluid collectors, as illustrated in Fig. 6d
and e. Accordingly, simple extraction of ISF using the MNs is
possible; external analysis may then be provided by means of
coupled electrodes (Fig. 6d) or centralized instrumentation
(Fig. 6e), i.e. traditional analytical instrumentation placed in the
laboratory (such as liquid chromatography [79] and optical sensing
[177], among others). Evidently, these latter analyses do not
formally pertain to wearable MN (bio)sensing technology. How-
ever, these approaches deserve special attention with regards to
effective solutions for the validation of pure on-body measure-
ments with MN (bio)sensors. For example, Miller et al. used a setup
consisting of MN coupled to a glass capillary to collect the ISF [79].
Seemingly, a flow of ISF was obtained for 10e15 min following a
delay of 30e120 s after insertion of the MN. Additionally, the au-
thors established that the ISF flow was not due to capillary effects,
but to the local pressure induced by the unique concentric geom-
etry of the MN. By using this approach, no additional equipment
(vacuum pump for example) were required for ISF collection.
Another approach consists of the enrichment of the MNs with
the target analyte during the skin insertion. Zhang et al. described a
methodology using MNs containing photonic crystal barcodes with
immobilized antibody probes, which were able to selectively cap-
ture three inflammatory cytokenes (TNF-a, IL-1b, and IL-6) [177].
Once captured, the complexed cytokenes reacted with fresh anti-
bodies in a typical sandwich immunocomplexes assay and were
measured by fluorescence. Similarly, Caffarel-Salvador et al. re-
ported on hydrogel-based MNs prepared from crosslinked
poly(methylvinylether-comaleic acid) [178]. When dry, these MNs
are able to easily penetrate the skin and, once inside, the hydrogel
absorbs moisture from the ISF and swells, allowing substances
present in the ISF to permeate into theMNs. After removal from the
MN, all the accumulated substances can be measured by conven-
tional analytical techniques. In this case, theophylline and caffeine
were analyzed by liquid chromatography with UV detection
whereas glucose was measured by means of a commercial
glucometer.
The last measuring scheme option involves the so-called on-line
measurements (Fig. 6d). MNs are used to sample ISF towards the
sensing platform, which is located in the same patch that contains
the MNs. Conveniently, some derivatization/pre-treatment pro-
cedures can be performed inside the MNs prior to reaching the
sensing platform. An example of this approach was reported by
Yang et al., who combined reverse iontophoresis and MNs to cap-
ture Epstein-Barr virus cell-free DNA (an important biomarker of
nasopharyngeal carcinoma), which was directly analyzed bymeans
of a voltammetric microfluidic-based biosensor based on recom-
binase polymerase amplification [179]. Thus, hydrogel-based MNs
were able to isolate DNA from the epidermis in aminimally invasive
manner thanks to the material of the MN (polymethyl vinyl ether-
alt-maleic hydrogel), which can capture and absorb DNA. The
microfluidic chip employed consisted of a two-layer structure
joined by plasma treatment: a microelectrode layer and a flow
channel layer. Themicroelectrode part included theWE (gold wire),
RE (Ag/AgCl) and CE (Pt wire). The microfluidic chip was nourished
by a mini-springe pump with a flow rate of 7.5 mL min1. Despite
the advantages provided with this measurement scheme, problems
related to the reliability of ISF extraction or a time delay associated
Table 5
In vivo and ex vivo applications of electrochemical MN sensors.
MN description Analysis Application Measuring
scheme
Monitoring
time
Calibration method Validation method Ref
Hollow:
Silicon
Glucose in ISF Diabetic human
volunteers
In vivo 72 h Calibration against
reference blood glucose
value
Comparison with
finger-pricked blood
analyzed by
commercial device
[95,142]
Solid:
PET functionalized with
GOx
Glucose in ISF Diabetic beagle
dogs, monkey
and human
volunteers
In vivo 5 days (dogs)
3 days (human)
NS Blood sampling and
analysis by reference
device (Accu-check
Performa)
[134]
Solid-coated:
SU8 coated with C and
functionalized with
GOx
Glucose in ISF Healthy human
volunteers
In vivo 3 h NS Comparison with
finger-pricked blood
analyzed by
commercial device
[16]
Hollow:
Silicon functionalized
with GOx
Glucose in ISF Healthy human
volunteers
In vivo 90 min NS Comparison with
finger-pricked blood
analyzed by
commercial device
[28]
Solid-coated:
Polycarbonate coated
with Pt and
functionalized with
GOx
Glucose in ISF Healthy and
diabetic human
volunteers
In vivo 24 h Calibration against
blood values 2 h after
insertion.
External calibration
post-removal
Blood sampling and
analysis by reference
laboratory method (YSF
glucose analyzer)
[147]
Solid-coated:
SST coated with AuNP/
PtNP and
functionalized with
GOx
Glucose in blood Anesthetized
male mice
In vivo 3 h Calibration in PBS after
on-body measurements
Blood sampling and
analysis by glucose
testing strips
[140]
Solid:
SU8 functionalized
with GOx or LOx
Glucose and lactate in ISBF Anesthetized
male rats
In vivo 3 h Calibration in PBS
before and after on-
body measurement
No validation [104]
Solid-coated:
b-lactamase
functionalized MN
Phenoxymethylpenicillin in
ECF
Healthy human
volunteers
In vivo 6 h Plotting of random
timepoints against
microdialysis data
ECF is extracted by
microdialysis and
analyzed by HPLC-MS
[157]
Solid-coated:
Polycarbonate coated
with Cr/AU and
functionalized with
b-lactamase
Penicillin in ISF Healthy human
volunteers
In vivo 6 h Calibration in PBS
before and after on-
body measurement
ECF is extracted by
microdialysis and
analyzed by HPLC-MS
[148]
Solid-coated:
PCL coated with PEDOT
and functionalized
with hemin
Nitric oxide in ISF Anesthetized
healthy and
melanoma
mice
In vivo/Ex vivo 5 min No calibration Confirmation of
melanoma diagnosis
through
endomicroscopy
[123]
Solid coated:
W coated with ZnO
pH in CSF and bladder Anesthetized
female mice
In vivo 60 s External calibration in
buffer
CSF and bladder urine
collection and analysis
by portable pH-meter
[73]
Solid-coated:
SST coated with Pt/rGO
H2O2 in ISF Pig skin
Living mice
Ex vivo/In vivo 90 s
400 s
External calibration in
PBS
Skin tissues are minced
and quantified with
H2O2 kit
[124]
Hollow-pyramidal:
Filled with carbon paste
containing OPH
MPOx in ISF Mice skin Ex vivo 30 s External calibration in
artificial ISF
Exposing mice skin to
MPOx and calculating
recoveries
[107]
Solid-coated:
PET coated with Au/
IrOx
pH in heart Explanted
hearts from
male rats
Ex vivo 70 min External calibration: 2
points in buffer and 1
point in Tyrode's
solution with the heart,
last point repeated
post-removal
No validation [137]
COC: cyclic olefin copolymer; CSF: cerebrospinal fluid; ECF: extracellular fluid; GOx: glucose oxidase; ISBF: interstitial brain fluid; ISF: interstitial fluid; LOx: lactate oxidase;
MPOx: methyl paraoxon; NP: nanoparticle; NS: not specified; OPH: organophosphorus hydrolase; PCL: polycarprolactone; PEDOT: poly(3,4-ethylenedioxythiophene); PET:
polyethylene terephthalate; SST: stainless steel.
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claimed in the literature [179].
4.2. Particular and traditional analytical requirements for MN (bio)
sensors
Major challenges to reliable in vivo analysis are found in the
proper calibration and validation of the MN (bio)sensors. In fact,
most of the works reported in the last decade have been limited to
the monitoring of analyte changes, not being able to provide a20validated quantification. In the case of glucose, as the main com-
pound analyzed with MN-based measurements, some authors
have proposed the calibration of glucose MN sensors against the
values obtained in blood [95,142,147]. Random intensity values
(from amperometry measurements) obtained in ISF are plotted
against blood concentration (from glucometer measurements), at
the corresponding time, in order to calibrate the sensors. Never-
theless, this procedure should be avoided because it may provide
biased results that do not consider concentration differences be-
tween simultaneous measurements in ISF and blood due to the
Fig. 6. Scheme of most common approaches in the employment of MN sensors: A) a MN sensor patch placed on human skin, B) on-body MN sensor based on external modification,
C) on-body MN based on internal modification, D) online MN sensor and E) off-body measurements using MN.
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bration would be valid only for glucose, and perhaps lactate with
the use of the lactometer, but it is not a general protocol for
calibration (and neither for validation) of ISF (or other) in vivo
measurements.
Any protocol generally involves the calibration of the MN sen-
sors before and after the in vivo application. Besides obvious
quantification purposes, this double calibration allows one to
evaluate any effect of the skin penetration process in the sensor
response. Also, this double calibration may help to correct drifts
and assess biofouling processes [104,157]. Thus, with optimal ac-
curacy as the intention, it is crucial to select appropriate calibration
conditions in terms of number of datapoints, background, and set
up. For example, some authors have performed external calibra-
tions in buffer solution rather than using the artificial version of the
corresponding biological fluid [73,124]. Although this practice
could be claimed to be an adequate alternative in the case of ISF
because of its simplicity compared to blood, ISF still contains
different ions and some small organic molecules (such as sodium,
magnesium, calcium, CO2, glucose and albumin) that can result in a
matrix effect in the sensor response [85].
Maintenance of the calibration parameters of MN (bio)sensors
after skin insertion has been generally considered in the literature
as a sign of robustness and reliability of the external calibration in
quantifying analyte concentrations [104,148]. In this case, a
threshold value should be set to establish the accepted difference in
the parameters before and after calibration. Vasylieva et al. set the
threshold for the slope (or sensitivity) at 40% [104]. However,
considering that their aimwas the development of a medical device
for health evaluation, a more discrete threshold of <20% (as in the
case of commercially available glucometers) would be a more
suitable value to further pursue in vivo measurements. Indeed, it is
evident that this approach can only guarantee that MN sensors are
not affected or altered during in vivo measurements because of the
insertion process). Overall, the calibration protocol evidently re-
mains controversial in wearable MN technology.
In one particular case, MN sensors have been used to confirm
the presence of the analytewithout the need for a calibration graph
to quantify its concentration. Keum et al. developed a MN sensor to
monitor melanoma via concentration of nitric oxide in the colon of
mice [123]. The MNs were placed at the end of an endomicroscope,21which additionally served to collect polyps. The main indicator of
the presence of cancer was a change in the current recorded by the
MNs due to the increase of nitric oxide (produced by nitric oxide
synthase in the cancerous region), such that an exact value of its
concentration was not required and, therefore, calibration was not
necessary. The validation step was performed by using a biopsy of
the polyp region [123].
Apart from this specific example, finding a suitable calibration
protocol for each particular analyte is a challenge, mainly due to the
difficulty in translating in vivo conditions to an in vitro set up, in
addition to alterations that the sensor could experience during skin
penetration or the in vivo measurement per se. Hydrodynamics or
changes in mass transport conditions can impact also on the sensor
response [148]. Up to this point, traditional calibration protocols
have been adapted to the special conditions required for reliable ISF
analysis with MNs. For example, Zuliani et al. impressively moni-
tored the pH in a mouse's heart immersed in a Tyrode solution
(isotonic solution based on ISF matrix) over ischemia/reperfusion
episodes [137]. For this purpose, a two-point calibration was per-
formed before the ex vivo experiment to find the slope in buffer
solutions and a one-point calibration was performed in the Tyrode
solution to adjust the offset, assuming that the slope of the cali-
bration graph was not altered. This last calibration point was
repeated after each ischemia/reperfusion assay. It was demon-
strated that the offset was linearly changing over time, and
accordingly, drift corrections were accomplished.
Regarding the validation strategy, and returning to the case of
glucose, most of the reported MNs analyzed either ISF or blood, and
used a validation method that involves blood glucose analyses with
commercial glucometers. In the case of ISF analysis, this validation
approach evidently assumes equal concentration of glucose in ISF
and blood, setting aside the fact that the veracity of this assumption
is time-dependent, as already illustrated in previous sections.
While this approach could not even be considered a pure validation
protocol (because the two techniques which are compared do not
consider the same biological fluid), it allows for an approximated
comparison between blood and ISF glucose pursuing reliable cor-
relation studies. This method is of course totally acceptable for
glucose analysis in blood.
In principal, validation strategies should be based on the
extraction of the targeted body fluid. To this end, finger pricking,
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Rawson et al. determined penicillin in extracellular fluid and the
results were validated using microdialysis to extract serum sam-
ples, which were later analyzed by high performance liquid chro-
matography coupled to mass spectrometry [157]. It was possible to
observe similarities between the time-profiles obtained with the
MN device and the gold standard technique, indicating a suitable
on-body monitoring of the drug with MNs. Mani et al. used MN
sensors to measure pH in brain and bladder samples obtained from
mice with a validation protocol involving the extraction of cere-
brospinal fluid and urine by means of aspiration through a 33-
gauge needle attached to a polyurethane tube and inserted into
the brain and bladder [73]. Then, the samples were analyzed with a
commercial pH meter. The values obtained were always higher in
the case of the commercial pH meter. Hence, the authors assumed
that pH changes could occur simply upon extraction of the fluid
from the mouse body. These results indeed accentuate a reasonable
explanation for the lack of validation protocols in ISF measure-
ments with MNs, this being the lack of reliable methods for
extraction or collection of the ISF volume needed for analysis with a
gold standard technique.
Concerning lifetime requirements to address in vivo mea-
surements, one of the advantages of using MN sensors is the
possibility for real-time, continuous monitoring, which can
facilitate the daily monitoring of ill people in the clinical field. In
addition, considering the options beyond punctual clinical
measurements, it is important to evaluate the resiliency of the
MN sensors facing certain corporal movements. This is in turn
significant toward possible applications in assessment of sport
performance. On the one hand, few in vivo studies have been
carried out for periods longer than 24 h [95,134,142,147] to
demonstrate the long-term suitability of the technology: a good
practice could be based on disposable patches that can be
replaced every 24 h (or any other time frame). On the other
hand, there is a lack of information about resiliency studies and
the manner in which corporal movement affects MN sensors
during in vivo assays, whereas this sort of assay has been suc-
cessfully addressed in previous steps (ex vivo conditions). For
example, Ciui et al. explored the consequences of twisting and
bending repetitively a tyrosinase MN sensor on the recorded
signal [37].
Toxicity-related experiments are also essential towards in vivo
demonstration of MN sensor operation, which may limit the
wearable lifetime of theMN patch. Even if this topic seems obvious,
unexpected lack of information can be appreciated in the literature
involving in vivo assays, with the majority of the works only
mentioning the use of biocompatible materials (such as ZnO [73],
IrO2 [148], silicon substrates [95,104] and mussel protein [134],
among others) but not performing pure cytotoxicity assays.
Contrarily, other authors employ substances which cannot clearly
be considered non-toxic (e.g., tetrathiafulvalene [16] and organo-
phosphorus hydrolase [107]). In the cases where not all substances/
materials are entirely biocompatible, it is important to be able to
prove that there is no risk for human health during the entire
employment of the device. For this purpose, two main circum-
stances must be confirmed: (i) no leaking of any substance during
the use of the device, and (ii) the corresponding cytotoxicity assays
indicating that skin (or tissue) cells are not negatively affected by
contact with the sensor. In this context, our previous work with
potentiometric MNs for potassium can be highlighted as a suitable
example [138], together with our recent paper about cytotoxicity
studies involving ionophore-based membranes regularly used in
potentiometric sensing of ions [143]. Owing to these studies, it is
possible to establish limits for the continuous use of the MN (bio)
sensors without compromising the patient's health (for example, at22least 24 h with MNs for the potentiometric detection of potassium)
[138,143].
Despite positive results arising in cytotoxicity studies, this is not
enough to obtain the medical approval for the studies required
prior to market commercialization. The MN device must addition-
ally adhere to the regulations for medical devices (legislatives
rules), which are for example established by the United States
Federal Food and Drug Administration (U.S. FDA) in the USA, and
the European Union Medical Device directive in the EU. For each
new product, a standard document must be presented specifying
compliance to the rules and guidelines as well as providing the
instructions for its use in a certain environment, alongside the re-
sults demonstrating the quality of the product. This document
should be in alignment to the corresponding International Orga-
nization for Standardization (ISO) standard: mainly, ISO 9001, for
the business part and ISO 13845 for the issues related with medical
devices [180]. On-body measurements should also consider the ISO
10993 series, which establishes necessary assays such as genotox-
icity, cytotoxicity, local effects after implantation, intradermal
reactivity, sensitization as well as systemic and acute systemic
toxicity to ensure that the medical device is safe for humans during
testing procedures.
4.3. Analyzing particular examples demonstrated for in vivo
analysis with MNs
Among all the MN (bio)sensors reported in the literature in the
last decade, only 12 have been demonstrated for in vivo applica-
tions. Jina et al. used a patch based on an array of hollow MNs to
extract ISF towards Pt WEs modified with GOx and BSA for on-line
determination of glucose [142]. The authors set four of these de-
vices in the upper arm and forearm of 10 diabetic human subjects
(seven were of type 1 and three of type 2) subjects to monitor
glucose for 48 or 72 h. During this period, changes in glucose
concentration were induced through the manipulation of insulin
and diet. The system was initially calibrated using reference blood
glucose values obtained by finger pricking and recalibrated once
per day, which represents a lower calibration frequency than the
majority of the commercially available devices. Additionally, blood
reference values were measured every 20 min during daily hours
for validation purposes. A lag time of 17 min (determined in a prior
study with healthy volunteers) was applied to calibration and
validation values to account for the diffusion time between blood
and ISF. After this correction, a good correlation was observed be-
tween different devices carried out in the same subject as well as
between the values from the MN sensor array and the reference
fingerstick blood glucose values. The rather good correlation dis-
played over the entire study demonstrates the long-time opera-
bility of the developed device with only one calibration per day. On
the other hand, the impact of the device on the skin in terms of
irritation (erythema and edema) was also scored in a modified
Draize scale (scale 0e4, with higher numbers indicating more se-
vere irritation), showing an edema and erythema average score of
0.06 and 1.54, respectively. In all cases the damage was healed
without treatment in several days.
A similar protocol was used by Samavat et al. for the in vivo
determination of glucose using a GOx spray-coated MN sensor [16].
This device was tested with healthy volunteers, starting the
recording in a fasting state and then drinking 120 mL of Polycal®
complex carbohydrate drink to increase the concentration of
glucose. The amperometric current was allowed to stabilize for 2 h
before starting the protocol measurement and, finger prick read-
ings were collected every 15 min for comparison purposes. Quan-
tification was not achieved as the device was not calibrated,
although the plotting of current vs. blood reference values revealed
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the value of 17 min reported by Jina et al. [142]. Interestingly, the
authors explained this delay using two diffusional components, the
first related to the time needed for glucose diffusion from blood
vessels to ISF and the second to a limited diffusion in the epidermis
that hinders the movement of ISF through the sensing layer.
Higher accuracy in glucose detection may even be achieved
using algorithms that consider both temperature and time lag
compensations. Kim et al. developed the corresponding algo-
rithm by first testing their PET/GOx functionalized sensors with
beagles (dogs) and monkeys (Fig. 7a and b), assuming a similar
behavior in these animals as in humans [134]. Then, the device
was applied to the determination of glucose in 10 diabetic (typeFig. 7. Figures of in vivo assays: determination of glucose (a) in beagle dogs and (b) cynomo
permission from Ref. [134]), d) home-made insertion tool for the implantation of MN sens
employed for the determination of glucose (Reproduced with permission from Ref. [147])
ymethylpenicillin penicillin in human (Reproduced with permission from Ref. [157]), (j-m)
231) human volunteers (Fig. 7c). After stabilizing the sensor for one
day, an oral glucose tolerance test (OGTT) and a meal tolerance
test (MTT) were performed. In these tests, glucose concentration
was altered by drinking an oral glucose sample (in OGTT) or
consuming a standardized meal (in MTT), and glucose concen-
tration was determined every 60 s with the MN sensor. Venous
blood samples were collected for validation purposes before
glucose intake, every 15 min during the first hour after it, and
every 20 min for the next two hours. The vast majority of the
data obtained with the sensor is in agreement with that procured
from the venous blood measurements using a gold standard
technique (YSI 2300 STAT plus), revealing a better accuracy than
many commercial glucose monitoring systems. After a prolongedlgus monkey, (c) implanted glucose MN sensors in human volunteer (Reproduced with
or (Reproduced with permission from Ref. [28]), e) regular and portable potentiostats
, f-i) MN arrays insertion and resulting skin irritation for the monitoring of phenox-
determination of pH in rat brain (Reproduced with permission from Ref [73]).
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although in some cases red traces in the zone where the sensor
was attached could be observed. These traces disappeared during
the following 3 days.
The system employed in order to perform the insertion of MNs
into the skin is an important aspect which has not been very
frequently addressed in the literature. Ensuring a proper and deep
insertion that is stable for a prolonged time can be relatively
challenging due to the elastic nature of the skin. Also, insertion
speed is a key factor [181]. In this context, Ribet et al. used a
custom-made tool (Fig. 7d) to insert the MN device into human
volunteers’ forearmwith a speed of 3 m s1 and force of 5 N [28]. It
was necessary to secure the device further using adhesive tape to
maintain a suitable depth for the entire duration of the measure-
ments. This set up provided the necessary stability for the per-
formed measurements, but the authors suggested that a more
suitable arrangement should be developed if longer analysis times
(>24 h) or higher movement of the volunteers are to be considered.
The monitoring of glucose over time also consisted of a glucose
tolerance test with discrete finger pricked blood reference values
used for validation. The values obtained with the MN device
correlate well with blood reference values, taking into account a lag
time of 10 min.
Probably the most complete in vivo study for glucose determi-
nation using MN sensors with human volunteers was performed by
Sharma et al. [147]. This study involved 3 different phases. In phase
1 the glucose device (polycarbonate MNs coated with Pt, func-
tionalized with GOx and sterilized using gamma radiation) was
inserted for 6 h in 8 healthy volunteers to check their level of
tolerance for MN arrays. After this time, the device was removed
from the skin and the patient scored the sensation of pain ac-
cording to the so-called Visual Analogue Scale. The median score
for the pain was 10, much lower than that associated with the
insertion of an intravenous cannula (score of 30). Phase 2 involved
the insertion of the device in healthy volunteers for 24 h and was
aimed to investigate both the depth of penetration and any
movements or dislodgements that occurred during this period. A
non-invasive imaging technique (Optical Coherence Tomography)
was employed to evaluate the insertion performed in each case,
revealing that the insertion depth remained constant over the 24 h
testing time. Finally, Phase 3 involved 10 participants suffering from
type 1 diabetes. According to the participants, the pain inflicted by
the MN device was comparable to that inflicted by a commercial
device for glucose detection (Dexcom G4 Platinum), but lower than
the pain felt during the insertion of an intravenous cannula. In this
phase, both regular and portable potentiostats were used to eval-
uate the performance of the MN sensors with the motion of the
patient (Fig. 7e). Although the MN measurements lasted for 24 h,
the portable potentiostat encountered issues in maintaining elec-
trical connection at night; therefore, only day measurements were
evaluated. For comparison purposes, venous blood was sampled
every 30 min and analyzed by a reference method (YSI Glucose
Analyzer). Surprisingly, the obtained data did not present a con-
stant lag time, with results ranging between 0 and 15 min. Clarke
error grid analysis was applied for the comparison of MN sensors
and blood reference values, showing that 96.4% of the data fell
within the clinically acceptable zone, which proves the feasibility of
the MN device.
Other authors have reported the in vivo determination of glucose
in anesthetized rats/mice, which are usually employed as a first step
in proof-of-viability studies for sensors in real clinical contexts.
Chen et al. implanted their sensor close to the spinal cord of
anesthetized rats and secured it using a plastic adapter with elec-
trical connections [140]. Glucose concentration in ISFwasmeasured
for 200 min and compared to blood glucose levels obtained from24tail veins via glucose strips. Changes in glucose concentration were
induced through the intraperitoneal injection of glucose solution
and a good correlationwas observed between the response current
and the measured blood glucose values. Particularly, an increase of
30% in glucose blood concentration corresponded to an increase of
38% in the current obtained. Alternatively, insulin was injected to
decrease glucose concentration, observing a 42% and 47% decrease
in blood values and sensor current, respectively. In terms of skin
irritation, a minor inflammatory response was observed around the
MN sensor three days after the implantation. According to the au-
thors, the minimal level of inflammatory response is related to the
high biocompatibility of the polyvinylidene fluoride Nafion coating
materials.
In vivo assays with anesthetized rats were also performed by
Vasylieva et al. for the simultaneous determination of glucose and
lactate in the brain [104]. In this case, the electrodes were all
implanted in the motor cortex of the brain, using a single probe to
reduce the number of insertions and thereby avoid further brain
damage. The assays lasted between 3 and 5 h, over which time
insulin and glucose administration was employed to manipulate
glucose concentration. Manipulation of lactate concentration was
not possible due to the lack of a consensual treatment able to
induce changes in lactate concentrations without impacting
extracellular glucose concentrations. No validation procedure was
carried out for the obtained concentration values but, according to
the authors, they were in agreement with previously reported data.
Rawson et al. performed an in vivo assay for the determination
of phenoxymethylpenicillin in human volunteers [157]. This study
included 10 healthy volunteers who took a standard treatment dose
for bacterial infections in adults consisting of 6 oral doses of phe-
noxymethylpenicillin (500 mg every 6 h). MN patches including
threeWE arrays (b-lactamase based biosensor) referred to the same
RE (Fig. 7f) were attached to the participant's forearm with firm
pressure for 60 s and secured in place with transparent medical
dressing (Fig. 7g) before the final dose. MN biosensors recorded the
current for up to 6 h. Blood samples and extracellular fluid were
collected, via cannula and microdialysis respectively, at discrete
times and then analyzed by liquid chromatography coupled tomass
spectrometry for comparison purposes. MNs were calibrated
against microdialysis data after data collection. Similar trends and
values were obtained with MN sensors and the microdialysis
approach. Regarding the effect of MN attachment to the partic-
ipant's skin, red marks could be observed after removal of the de-
vice (Fig. 7h), which completely disappeared after 12 h (Fig. 7i).
In vivo assays at a lower temporal scale have also been carried
out with animals. Jin et al. reported the in vivo determination of
hydrogen peroxide in mice; their MN sensor setup consisted of
reduced graphene oxide and Pt nanoparticles [124]. The mice were
anesthetized and shaved prior to the measurement and the MN
patches were placed on the back. Before starting the measurement,
the sensors were left for 5 min inside the skin to allow for disso-
lution of a polyvinylpyrrolidone layer employed to protect the MN
sensor during the insertion. In this case, changes in hydrogen
peroxide concentrations were induced by subcutaneous or intra-
peritoneal injections of a PBS solution containing hydrogen
peroxide. In the case of intraperitoneal injections, the results
indicated a rapid diffusion of hydrogen peroxide from the intra-
peritoneal space to the local tissue near to the MNs. Additionally,
the effect of the MN patch in the skinwas evaluated by pressing the
patch onto the mice's back for 10 min and analyzing the skin tissue
after 12 h. No obvious signs of skin irritation or inflammation were
observed when compared to control skin tissue.
MN based sensors have also been tested in vivo for disease
screening using punctual measurements. Keum et al. screened co-
lon cancer in mice using hemin modified MN sensors for the
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cator for cancer progression. For this purpose, both normal and ill
mice were screened, and the increase in current observed was
greater for ill mice due to increased nitric oxide concentration. This
assay was carried out using a dual-diagnostic system comprising
the MN sensors and an intravital endomicroscope, which allowed
for the visualization (and collection) of polyps. Discrete measure-
ments were also carried out by Mani et al. for the determination of
pH in mouse brain and bladder (Fig. 7j-m) [73]. Access to these
organs required surgery and measurement time was limited to 60 s
to minimize the pain. Five healthy mice were included in the study
and both CSF and urine were collected by aspiration for comparison
purposes. Samples were immediately measured using a commer-
cial pHmeter, obtaining values slightly higher than those measured
with the MN sensors.4.4. MN sensors in the market
Despite the relatively high number of publications and the ef-
forts devoted to creating robust and reliable MN devices with the
corresponding in vivo studies, only a few examples have reached
the market (or show promise to do so). Table 6 summarizes the
current market scenario regarding MN sensors. There is a clear
market niche for glucose monitoring, most probably because dia-
betes treatment represents a huge worldwide market that is
regrettably expected to grow in the near future. In this context, MN
sensors may offer the key benefit of avoiding the unpleasant pro-
cess of extracting blood via finger pricks. In addition, continuous
glucose monitoring may provide much better control and foresight
to the patient, contributing to a considerable improvement in
health quality and well-being.
Only some companies have put efforts into the elaboration of
competitive products to satisfy this need. Dexcom [182] and Abbott
[183] have bid for wireless devices, which can be controlled by the
patient and/or doctor bymeans of a smartphone app. This approach
grants a more attractive product, clearly entrenching within the
minds of the costumers the idea of continuous monitoring; as at
any time and in any place they could simply take a look at their
smartphone screen to check their glucose level. On the other hand,
both Dexcom G6 CGM [39] and FreeStyle Libre 14 days [40] systems
are factory calibrated, which is a clear advantage to previous
models commercialized by the same companies, as there is no need
for recalibration by the end-user.
It is important to clarify that not every product sold for
“continuous glucose monitoring” actually offers exactly that. For
example, Medtronic [184] offers some MN products as sensors for
continuous glucose monitoring, but specifies in the warnings that
the data recorded is not available for the patient in real time, and
that this technology is not recommended as a total replacement for
conventional finger-prick blood. This clearly demonstrates the lack
of viability of this device in the context of this market.
There exist other companies which, while they do not yet have
any products on the market, have announced via their corre-
sponding websites the pending availability of powerful alternativesTable 6
Commercially advertised MN sensors.
Name Company Analyte
iPro 2 Professional CGM Medtronic Glucose
Dexcom G6 CGM Dexcom Glucose
FreeStyle Libre 14 days system Abbott Glucose
K'Watch Glucosea PK Vitality Glucose
K'Watch Athletea PK Vitality Lactate
a No commercial device is available yet/pending medical certification.
25for continuous glucose monitoring. For example, the website of PK
Vitality [185] includes a microneedle-based smartwatch product
[186]. This is an example of the company clearly following the
current trend in the smartwatch market: it is already commonly
possible to observe people wearing watches or bracelets that
monitor physical body functions such as steps, cardiac rhythm,
blood oxygen and sleeping cycles. Thus, such an analysis platform
already in the minds of costumers, and the implementation of new
sensors within this existing framework to evaluate more compli-
cated biomarkers would seem the path of least resistance in order
to keep ensuring profitable return from these products. In fact, PK
Vitality also claims that another of their promoted products,
K'Watch Athlete [187], will allow continuous monitoring of lactate,
again offering a smartwatch as the analysis platform, and focusing
heavily on an athletic or sporting target demographic. Lactate
monitoring is currently not in high demand, when compared to the
situation for glucose. Nevertheless, it remains highly possible that
elite level athletes and their corresponding support teams would
invest in such a device for the evaluation of lactate levels during
training in real time. It is not difficult to imagine that a more
complete control over the parameters of effort invested with
respect to the performance obtainedwould be beneficial, as the risk
of injury would be lowered. It goes without saying that injuries can
be absolutely ruinous to a sporting career. Furthermore, at this top
level of elite athletes, any improvement in performancewhatsoever
can mean the difference between success and failure, victory and
defeat.
When considering commercial products intended for domestic
use, thus far the only exploitation that has been undertaken (or is
visibly underway) pertains to continuous monitoring of glucose
and lactate. However, even in the case of glucose monitoring,
despite the appreciable demand the product portfolio to choose
from remains rather limited. According to the American Diabetes
Association [188], 327 billion dollars were spent on diabetes treat-
ment in 2018, clearly not a negligible sum. Therefore, there is a
large population of diabetic people that could and would use a
continuous glucose monitoring system based on MNs. In all likeli-
hood, the existence of a well-established system which chains
diabetic people to the blood finger strips in perpetuity, generating a
constant money flow to the companies producing these strips, is
the major braking force holding back advancements in this field.
Thus, MN systems must be made more expensive in order to
overcome the deficit imposed by the existing system. Above all, a
clear marketing strategymust be implemented in order to convince
diabetic people, who will be giving their money for these products,
of their worth.
5. Conclusions and future prospects
In the last decade considerable efforts have been directed, in the
development of electrochemical MN (bio)sensors, to establishing
many different approaches that integrate the sensing concept into
the MN platform while aiming to inflict minimal pain on the sub-
ject. In the majority of cases, the sensing event occurs trans-
dermally, once it has been verified that the analytical features of the
sensor remain constant after the skin penetration, and that an
external calibration of the sensor can serve to accurately quantify
the analyte concentration. However, only very fewMNdevices have
been used to demonstrate real in vivo measurements in animals
and humans; the rest remain at the in vitro and ex vivo stage
showing adequate performances through phantom gel and/or
sectioned animal skin. Although glucose is the principal analyte
targeted by electrochemical MN (bio)sensors, other species such as
lactate, drug compounds, nitric oxide, pH (hydrogen ions), and
other ions are gaining momentum. Thus, a shift has been noted
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tion to non-enzymatic approaches, with a view to more stable and
reliable sensors. It is possible to implement all of the electrodes
necessary to complete the electrochemical cell in only one MN or in
distinct MNs, each approach presenting its own advantages. In
addition, several works have put forward MN devices for multi-
analyte detection, for example for the simultaneous detection of
glucose and lactate. Regarding the assessment of the analytical
features of electrochemical MN (bio)sensors, this review points out
deficiencies in the protocols deployed for the calibration and vali-
dation of the sensors, together with a lack of biocompatibility
(cytotoxicity and inflammation) and durability studies. These fac-
tors, together with the difficulties encountered in attaining formal
approvals for in vivo studies, likely constitute a bottleneck for
electrochemical MN (bio)sensing technology when trying to
expand into the commercial market, or achieve a higher TRL. It is
strongly advisable that further research in the field focuses on these
aspects to fully take advantage of the great potential of MN sensors
towards continuous monitoring in healthcare.
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